KR20150115225A - An electroluminescent compound and an electroluminescent device comprising the same - Google Patents

An electroluminescent compound and an electroluminescent device comprising the same Download PDF

Info

Publication number
KR20150115225A
KR20150115225A KR1020140039903A KR20140039903A KR20150115225A KR 20150115225 A KR20150115225 A KR 20150115225A KR 1020140039903 A KR1020140039903 A KR 1020140039903A KR 20140039903 A KR20140039903 A KR 20140039903A KR 20150115225 A KR20150115225 A KR 20150115225A
Authority
KR
South Korea
Prior art keywords
group
substituted
unsubstituted
formula
compound
Prior art date
Application number
KR1020140039903A
Other languages
Korean (ko)
Other versions
KR101638073B1 (en
Inventor
현서용
정성욱
Original Assignee
(주)피엔에이치테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)피엔에이치테크 filed Critical (주)피엔에이치테크
Priority to KR1020140039903A priority Critical patent/KR101638073B1/en
Publication of KR20150115225A publication Critical patent/KR20150115225A/en
Application granted granted Critical
Publication of KR101638073B1 publication Critical patent/KR101638073B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention relates to an organic luminescent compound used in an organic electroluminescent device, which is represented by the following Chemical Formula 1 or Chemical Formula 2. The organic luminescent compound according to the present invention is used as a host compound and/or a dopant compound within a luminescent layer, thereby allowing an organic electroluminescent device having excellent luminescent properties such as a driving voltage, luminescence efficiency, and the like.

Description

유기발광 화합물 및 이를 포함하는 유기전계발광소자{An electroluminescent compound and an electroluminescent device comprising the same}TECHNICAL FIELD The present invention relates to an organic electroluminescent compound and an electroluminescent device comprising the same,

본 발명은 유기발광 화합물 및 이를 포함하여 저전압이 구동이 가능하여 전력효율이 우수하고, 동시에 우수한 발광효율 특성 구현이 가능한 유기전계발광소자에 관한 것이다.The present invention relates to an organic electroluminescent compound and an organic electroluminescent device including the same and capable of being driven at a low voltage and having excellent power efficiency and excellent luminescent efficiency characteristics.

유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등으로 이루어질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. 이러한 유기 발광 소자는 자발광, 고휘도, 고효율, 낮은 구동 전압, 넓은 시야각, 높은 콘트라스트, 고속 응답성 등의 특성을 갖는 것으로 알려져 있다.An organic light emitting phenomenon is a phenomenon that converts electric energy into light energy by using an organic material. An organic light emitting device using an organic light emitting phenomenon generally has a structure including an anode, a cathode, and an organic material layer therebetween. Here, in order to enhance the efficiency and stability of the organic light emitting device, the organic material layer may have a multi-layered structure composed of different materials and may include a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. When a voltage is applied between the two electrodes in the structure of such an organic light emitting device, holes are injected in the anode, electrons are injected into the organic layer in the cathode, excitons are formed when injected holes and electrons meet, When it falls back to the ground state, the light comes out. Such an organic light emitting device is known to have characteristics such as self-emission, high luminance, high efficiency, low driving voltage, wide viewing angle, high contrast, and high speed response.

유기 발광 소자에서 유기물층으로 사용되는 물질은 기능에 따라, 발광 물질과 전하 수송 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. 또한, 발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다.A material used as an organic material layer in an organic light emitting device can be classified into a light emitting material and a charge transporting material, a hole injecting material, a hole transporting material, an electron transporting material, and an electron injecting material depending on functions. In addition, the luminescent material can be classified into blue, green and red luminescent materials and yellow and orange luminescent materials necessary for realizing a better natural color depending on the luminescent color.

한편, 발광 물질로서 하나의 물질만 사용하는 경우 분자간 상호 작용에 의하여 최대 발광 파장이 장파장으로 이동하고 색순도가 떨어지거나 발광 감쇄 효과로 소자의 효율이 감소되는 문제가 발생하므로, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여 발광 물질로서 호스트/도판트 계를 사용할 수 있다.On the other hand, when only one material is used as the light emitting material, there arises a problem that the maximum light emitting wavelength shifts to a long wavelength due to intermolecular interaction, the color purity drops, or the efficiency of the device decreases due to the light emission attenuating effect. A host / dopant system may be used as a light emitting material in order to increase the efficiency of light emission through the light emitting layer.

유기 발광 소자가 전술한 우수한 특징들을 충분히 발휘하기 위해서는 소자 내 유기물층을 이루는 물질, 예컨대 정공 주입 물질, 정공 수송 물질, 발광 물질, 전자 수송 물질, 전자 주입 물질 등이 안정하고 효율적인 재료에 의하여 뒷받침되는 것이 선행되어야 하나, 아직까지 안정하고 효율적인 유기 발광 소자용 유기물층 재료의 개발이 충분히 이루어지지 않은 상태이다. 따라서 새로운 재료의 개발이 계속 요구되고 있으며, 이와 같은 재료 개발의 필요성은 전술한 다른 유기 전자 소자에서도 마찬가지이다.In order for the organic luminescent device to sufficiently exhibit the above-described excellent characteristics, a material constituting the organic material layer in the device, such as a hole injecting material, a hole transporting material, a luminescent material, an electron transporting material and an electron injecting material is supported by a stable and efficient material However, development of a stable and efficient organic material layer material for an organic light emitting device has not yet been sufficiently developed. Therefore, development of new materials is continuously required, and the necessity of developing such materials is the same in other organic electronic devices described above.

청색발광물질로서 미국 등록특허 제US 7053255 에는 중심부는 디페닐안트라센 구조를 가지며, 아릴기가 말단에 치환된 청색 발광 화합물 및 이를 이용한 유기전계발광소자가 개시되어 있지만 발광효율 및 휘도가 충분하지 않다는 문제점이 있다. 한편, 미국등록특허공보 제US 7233019호, 대한민국공개특허공보 제2006-0006760호에는 치환된 피렌계 화합물을 이용한 유기전계발광소자가 개시되어 있으나, 청색의 색순도가 낮아서 진한 청색(deep blue)의 구현이 어렵기 때문에 천연색의 풀컬러 디스플레이를 구현하는데 문제점이 있다.As a blue light emitting material, US Pat. No. 7053255 discloses a blue light emitting compound having a diphenyl anthracene structure and an aryl group substituted at the terminal thereof, and an organic electroluminescent device using the blue light emitting compound. However, have. On the other hand, US Pat. No. 7233019 and Korean Patent Laid-Open Publication No. 2006-0006760 disclose an organic electroluminescent device using a substituted pyrene compound. However, since the color purity of blue is low, a deep blue It is difficult to realize a full-color full-color display.

본 발명은 유기전계발광소자의 유기층에 채용되어 저전압 구동 및 우수한 발광 특성을 구현할 수 있는 신규한 유기발광 화합물과 이를 포함하는 유기전계발광소자를 제공하고자 한다.The present invention provides a novel organic electroluminescent compound which is employed in an organic layer of an organic electroluminescent device and can realize low voltage driving and excellent luminescent characteristics, and an organic electroluminescent device including the same.

본 발명은 상기 과제를 해결하기 위하여, 하기 [화학식 1] 내지 [화학식 2]로 표시되는 유기발광 화합물을 제공한다.In order to solve the above-described problems, the present invention provides an organic luminescent compound represented by the following formulas (1) to (2).

[화학식 1][Chemical Formula 1]

Figure pat00001
Figure pat00001

[화학식 2](2)

Figure pat00002
Figure pat00002

상기 [화학식 1] 내지 [화학식 2]의 구체적인 구조 및 치환기에 대해서는 후술한다.The specific structures and substituents of the above formulas (1) to (2) will be described later.

또한, 본 발명은 제1 전극, 제2 전극, 및 상기 제1 전극과 제2 전극 사이에 배치된 1층 이상의 유기물층을 포함하는 유기전계발광소자로서, 상기 유기물층 중 1 층 이상은 상기 [화학식 1] 또는/및 [화학식 2]로 구현되는 1종 이상의 유기발광 화합물을 포함하는 유기전계발광소자를 제공한다.Also, the present invention is an organic electroluminescent device comprising a first electrode, a second electrode, and at least one organic material layer disposed between the first electrode and the second electrode, wherein at least one of the organic material layers is represented by Formula 1 Or an organic electroluminescent compound represented by the following formula (2).

본 발명에 따른 유기발광 화합물을 유기물층에 포함하는 유기전계발광소자는 청색의 색순도 및 발광효율이 우수하고, 동시에 저전압 구동이 가능하여 전력효율 또한 우수하여 디스플레이 및 조명 등에 유용하게 사용될 수 있다.The organic electroluminescent device including the organic electroluminescent compound according to the present invention in the organic material layer has excellent color purity and luminous efficiency of blue color and can be driven at low voltage and is excellent in power efficiency and can be used for display and illumination.

도 1 내지 5는 본 발명의 일 실시예에 따른 유기전계발광소자의 구조를 예시한 단면도이다.1 to 5 are cross-sectional views illustrating the structure of an organic electroluminescent device according to an embodiment of the present invention.

이하, 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described more specifically.

본 발명은 유기전계발광소자의 유기층에 채용되는 발광화합물로서, 하기 [화학식 1] 또는 [화학식 2]로 표시되는 것을 특징으로 한다.The present invention is a luminescent compound employed in an organic layer of an organic electroluminescent device, and is characterized by being represented by the following formula (1) or (2).

특히, [화학식 1]로 표시되는 유기발광 화합물은 발광층의 호스트 화합물로서, [화학식 2]로 표시되는 유기발광 화합물은 발광층의 도펀트 화합물로 채용될 수 있다.In particular, the organic luminescent compound represented by the formula (1) is a host compound in the luminescent layer, and the organic luminescent compound represented by the formula (2) can be employed as a dopant compound in the luminescent layer.

[화학식 1][Chemical Formula 1]

Figure pat00003
Figure pat00003

[화학식 2](2)

Figure pat00004
Figure pat00004

상기 [화학식 1] 내지 [화학식 2]에서,In the above Chemical Formulas 1 to 2,

L1 내지 L4는 서로 동일하거나 상이하고, 각각 독립적으로 단일결합이거나, 치환 또는 비치환된 아릴렌기, 치환 또는 비치환된 알케닐렌기, 치환 또는 비치환된 플루오레닐렌기, 치환 또는 비치환된 카바졸릴렌기 또는 N, O 및 S 원자 중 1개 이상을 포함하는 치환 또는 비치환된 헤테로아릴렌기일 수 있다.L 1 to L 4 are the same or different and are each independently a single bond, a substituted or unsubstituted arylene group, a substituted or unsubstituted alkenylene group, a substituted or unsubstituted fluorenylene group, a substituted or unsubstituted Or a substituted or unsubstituted heteroarylene group containing at least one of N, O and S atoms.

Ar1은 치환 또는 비치환된 알킬기, 치환 또는 비치환된 시클로알킬기, 치환 또는 비치환된 알콕시기, 치환 또는 비치환된 아릴옥시기, 치환 또는 비치환된 알킬티옥시기, 치환 또는 비치환된 아릴티옥시기, 치환 또는 비치환된 알킬술폭시기, 치환 또는 비치환된 아릴술폭시기, 치환 또는 비치환된 알케닐기, 치환 또는 비치환된 실릴기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 알킬아민기, 치환 또는 비치환된 아랄킬아민기, 치환 또는 비치환된 아릴아민기, 치환 또는 비치환된 헤테로아릴아민기, 치환 또는 비치환된 아릴기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 카바졸기 또는 N, O 및 S 원자 중 1개 이상을 포함하는 치환 또는 비치환된 헤테로고리기일 수 있다.Ar 1 represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted alkylthio group, a substituted or unsubstituted aryl A substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, An alkylamine group, a substituted or unsubstituted aralkylamine group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted heteroarylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted fluorenyl group, A substituted or unsubstituted carbazole group, or a substituted or unsubstituted heterocyclic group containing at least one of N, O and S atoms.

R1 내지 R13은 서로 동일하거나 상이하고, 각각 독립적으로 수소, 중수소, 할로겐기, 니트릴기, 니트로기, 히드록시기, 치환 또는 비치환된 알킬기, 치환 또는 비치환된 시클로알킬기, 치환 또는 비치환된 알콕시기, 치환 또는 비치환된 아릴옥시기, 치환 또는 비치환된 알킬티옥시기, 치환 또는 비치환된 아릴티옥시기, 치환 또는 비치환된 알킬술폭시기, 치환 또는 비치환된 아릴술폭시기, 치환 또는 비치환된 알케닐기, 치환 또는 비치환된 실릴기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 알킬아민기, 치환 또는 비치환된 아랄킬아민기, 치환 또는 비치환된 아릴아민기, 치환 또는 비치환된 헤테로아릴아민기, 치환 또는 비치환된 아릴기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 카바졸기 또는 N, O, S 원자 중 1개 이상을 포함하는 치환 또는 비치환된 헤테로고리기일 수 있다.R 1 to R 13 are the same or different from each other and are each independently selected from the group consisting of hydrogen, deuterium, halogen, nitrile, nitro, hydroxy, substituted or unsubstituted alkyl, A substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted alkylthio group, a substituted or unsubstituted arylthioxy group, a substituted or unsubstituted alkylsulfoxy group, a substituted or unsubstituted arylsulfoxy group, A substituted or unsubstituted alkyl group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted boron group, a substituted or unsubstituted alkylamine group, a substituted or unsubstituted aralkylamine group, A substituted or unsubstituted heteroaryl group, a substituted or unsubstituted heteroarylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted carbazole group or an atom of N, O, S Or a substituted or unsubstituted heterocyclic group.

n, b, c, d, e, f 및 g는 각각 독립적으로 0 또는 1이며, m 및 p는 0 내지 7의 정수이다.
n, b, c, d, e, f and g are each independently 0 or 1, and m and p are integers of 0 to 7.

또한, 본 발명에 있어서, 상기 [화학식 1]로 표시되는 유기발광 화합물은 하기 [화학식 1-1] 내지 [화학식 1-3] 중 어느 하나로 표시될 수 있다.Further, in the present invention, the organic luminescent compound represented by the above formula (1) may be represented by any one of the following formulas (1-1) to (1-3).

[화학식 1-1][Formula 1-1]

Figure pat00005
Figure pat00005

[화학식 1-2][Formula 1-2]

Figure pat00006
Figure pat00006

[화학식 1-3][Formula 1-3]

Figure pat00007
Figure pat00007

상기 [화학식 1-1] 내지 [화학식 1-3]에서, R1, R2 및 Ar1은 상기 [화학식 1]에서의 정의와 동일하다.
In the formulas (1-1) to (1-3), R 1 , R 2 and Ar 1 are the same as defined in the formula (1).

또한, 본 발명에 있어서, 상기 [화학식 2]로 표시되는 화합물은 하기 [화학식 2-1] 내지 [화학식 2-5] 중 어느 하나로 표시될 수 있다.In the present invention, the compound represented by the formula (2) may be represented by any one of the following formulas (2-1) to (2-5).

[화학식 2-1][Formula 2-1]

Figure pat00008
Figure pat00008

[화학식 2-2][Formula 2-2]

Figure pat00009
Figure pat00009

[화학식 2-3][Formula 2-3]

Figure pat00010
Figure pat00010

[화학식 2-4][Chemical Formula 2-4]

Figure pat00011
Figure pat00011

[화학식 2-5][Chemical Formula 2-5]

Figure pat00012
Figure pat00012

상기 [화학식 2-1] 내지 [화학식 2-5]에서, R4 내지 R11은 상기 [화학식 2]에서의 정의와 동일하다.
In the above formulas (2-1) to (2-5), R 4 to R 11 are the same as defined in the above formula (2).

본 발명에 있어서, 상기 치환기들의 예시들에 대해서 아래에서 구체적으로 설명하나, 이에 한정되는 것은 아니다.In the present invention, examples of the substituents will be specifically described below, but the present invention is not limited thereto.

본 발명에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 50인 것이 바람직하다. 구체적인 예로는 메틸기, 에틸기, 프로필기, n-프로필기, 이소프로필기, 부틸기, n-부틸기, 이소부틸기, tert-부틸기, sec-부틸기, 1-메틸-부틸기, 1-에틸-부틸기, 펜틸기, n-펜틸기, 이소펜틸기, 네오펜틸기, tert-펜틸기, 헥실기, n-헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 4-메틸-2-펜틸기, 3,3-디메틸부틸기, 2-에틸부틸기, 헵틸기, n-헵틸기, 1-메틸헥실기, 시클로펜틸메틸기, 시클로헥틸메틸기, 옥틸기, n-옥틸기, tert-옥틸기, 1-메틸헵틸기, 2-에틸헥실기, 2-프로필펜틸기, n-노닐기, 2,2-디메틸헵틸기, 1-에틸-프로필기, 1,1-디메틸-프로필기, 이소헥실기, 2-메틸펜틸기, 4-메틸헥실기, 5-메틸헥실기 등이 있으나, 이들에 한정되지 않는다.In the present invention, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 50. Specific examples include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, Ethyl, propyl, isopropyl, n-butyl, isobutyl, isobutyl, isobutyl, A tert-butyl group, a tert-butyl group, a 2-pentyl group, a 3,3-dimethylbutyl group, a 2-ethylbutyl group, a heptyl group, Ethylhexyl group, 2-propylpentyl group, n-nonyl group, 2,2-dimethylheptyl group, 1-ethyl-propyl group, 1,1-dimethyl-propyl group , Isohexyl group, 2-methylpentyl group, 4-methylhexyl group, 5-methylhexyl group and the like, but are not limited thereto.

본 발명에 있어서, 알콕시기는 직쇄 또는 분지쇄일 수 있다. 알콕시기의 탄소수는 특별히 한정되지 않으나, 입체적 방해를 주지 않는 범위인 1 내지 30개인 것이 바람직하다. 구체적으로, 메톡시기, 에톡시기, n-프로폭시기, 이소프로폭시기, i-프로필옥시기, n-부톡시기, 이소부톡시기, tert-부톡시기, sec-부톡시기, n-펜틸옥시기, 네오펜틸옥시기, 이소펜틸옥시기, n-헥실옥시기, 3,3-디메틸부틸옥시기, 2-에틸부틸옥시기, n-옥틸옥시기, n-노닐옥시기, n-데실옥시기, 벤질옥시기, p-메틸벤질옥시기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the alkoxy group may be linear or branched. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably in the range of 1 to 30, which does not cause steric hindrance. Specific examples thereof include a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, an i-propyloxy group, a n-butoxy group, an isobutoxy group, a tert- , Neopentyloxy group, isopentyloxy group, n-hexyloxy group, 3,3-dimethylbutyloxy group, 2-ethylbutyloxy group, n-octyloxy group, n- , A benzyloxy group, a p-methylbenzyloxy group, and the like, but are not limited thereto.

본 발명에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 구체적인 예로는 비닐기, 1-프로페닐기, 이소프로페닐기, 1-부테닐기, 2-부테닐기, 3-부테닐기, 1-펜테닐기, 2-펜테닐기, 3-펜테닐기, 3-메틸-1-부테닐기, 1,3-부타디에닐기, 알릴기, 1-페닐비닐-1-일기, 2-페닐비닐-1-일기, 2,2-디페닐비닐-1-일기, 2-페닐-2-(나프틸-1-일)비닐-1-일기, 2,2-비스(디페닐-1-일)비닐-1-일기, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present invention, the alkenyl group may be straight-chain or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. Specific examples include a vinyl group, a 1-propenyl group, an isopropenyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a 1-pentenyl group, a 2-pentenyl group, a 3-pentenyl group, 2-phenylvinyl-1-yl group, 2,2-diphenylvinyl-1-yl group, 2-phenyl-2-yl group, But are not limited to, - (naphthyl-1-yl) vinyl-1-yl group, 2,2-bis (diphenyl-1-yl) vinyl-1-yl group, stilbenyl group, styrenyl group and the like.

본 발명에 있어서, 아릴기는 단환식 또는 다환식일 수 있고, 탄소수는 특별히 한정되지 않으나 6 내지 60인 것이 바람직하다. 단환식 아릴기의 예로는 페닐기, 비페닐기, 터페닐기, 스틸벤기 등이 있고, 다환식 아릴기의 예로는 나프틸기, 안트라세닐기, 페난트레닐기, 파이레닐기, 페릴레닐기, 테트라세닐기, 크라이세닐기, 플루오레닐기, 아세나프타센닐기, 트리페닐렌기, 플루오안트렌(fluoranthrene)기 등이 있으나, 본 발명의 범위가 이들 예로만 한정되는 것은 아니다.In the present invention, the aryl group may be monocyclic or polycyclic, and the number of carbon atoms is not particularly limited, but is preferably 6 to 60. [ Examples of the monocyclic aryl group include a phenyl group, a biphenyl group, a terphenyl group and a stilbene group. Examples of the polycyclic aryl group include a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, a perylenyl group, , A chlorenyl group, a fluorenyl group, an acenaphthacenyl group, a triphenylene group, and a fluororanthrene group, but the scope of the present invention is not limited to these examples.

본 발명에 있어서, 헤테로고리기는 이종원자로 O, N 또는 S를 포함하는 헤테로고리기로서, 탄소수는 특별히 한정되지 않으나 탄소수 2 내지 60인 것이 바람직하다. 헤테로고리기의 예로는 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딜기, 비피리딜기, 피리미딜기, 트리아진기, 트리아졸기, 아크리딜기, 피리다진기, 피라지닐기, 퀴놀리닐기, 퀴나졸린기, 퀴녹살리닐기, 프탈라지닐기, 피리도 피리미디닐기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀린기, 인돌기, 카바졸기, 벤조옥사졸기, 벤조이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨라닐기, 디벤조퓨라닐기, 페난트롤린기, 티아졸릴기, 이소옥사졸릴기, 옥사디아졸릴기, 티아디아졸릴기, 벤조티아졸릴기, 페노티아지닐기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present invention, the heterocyclic group is a heterocyclic group containing O, N or S as a heteroatom, and the number of carbon atoms is not particularly limited, but is preferably 2 to 60 carbon atoms. Examples of the heterocyclic group include a thiophene group, a furane group, a furyl group, an imidazole group, a thiazole group, an oxazole group, an oxadiazole group, a triazole group, a pyridyl group, a bipyridyl group, a pyrimidyl group, A pyridazinyl group, a pyrazinopyrazinyl group, an isoquinoline group, a pyrazinyl group, a pyrazinyl group, a pyrazinyl group, a pyrazinyl group, a quinolinyl group, a quinazolinyl group, a quinoxalinyl group, a phthalazinyl group, a pyridopyrimidinyl group, , An indole group, a carbazole group, a benzoxazole group, a benzoimidazole group, a benzothiazole group, a benzocarbazole group, a benzothiophene group, a dibenzothiophene group, a benzofuranyl group, a dibenzofurancyl group, a phenanthroline group, An isothiazolyl group, an isoxazolyl group, an oxadiazolyl group, a thiadiazolyl group, a benzothiazolyl group, a phenothiazinyl group and the like, but is not limited thereto.

본 발명에 있어서, 아릴옥시기, 아릴티옥시기, 아릴술폭시기 및 아랄킬아민기 중의 아릴기는 전술한 아릴기의 예시와 같다. 구체적으로 아릴옥시기로는 페녹시기, p-토릴옥시기, m-토릴옥시기, 3,5-디메틸-페녹시기, 2,4,6-트리메틸페녹시기, ptert-부틸페녹시기, 3-비페닐옥시기, 4-비페닐옥시기, 1-나프틸옥시기, 2-나프틸옥시기, 4-메틸-1-나프틸옥시기, 5-메틸-2-나프틸옥시기, 1-안트릴옥시기, 2-안트릴옥시기, 9-안트릴옥시기, 1-페난트릴옥시기, 3-페난트릴옥시기, 9-페난트릴옥시기 등이 있고, 아릴티옥시기로는 페닐티옥시기기, 2-메틸페닐티옥시기, 4-tert-부틸페닐티옥시기 등이 있으며, 아릴술폭시기로는 벤젠술폭시기, p-톨루엔술폭시기 등이 있으나, 이에 한정되지 않는다.In the present invention, the aryl group in the aryloxy group, arylthioxy group, arylsulfoxy group and aralkylamine group is the same as the aforementioned aryl group. Specific examples of the aryloxy group include a phenoxy group, a p-tolyloxy group, an m-tolyloxy group, a 3,5-dimethyl-phenoxy group, a 2,4,6-trimethylphenoxy group, a ptert- Anthryloxy group, 2-naphthyloxy group, 2-naphthyloxy group, 4-methyl-1-naphthyloxy group, Anthryloxy group, 9-anthryloxy group, 1-phenanthryloxy group, 3-phenanthryloxy group, 9-phenanthryloxy group and the like. Examples of the arylthioxy group include phenylthioxy group, 2- A 4-tert-butylphenyloxy group, and the like. Examples of the arylsulfoxy group include benzene sulfoxy group and p-toluenesulfoxy group. However, the present invention is not limited thereto.

본 발명에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 구체적으로 시클로프로필기 시클로부틸기 시클로펜틸기 3-메틸시클로펜틸기 2,3-디메틸시클로펜틸기, 시클로헥실기, 3-메틸시클로헥실기, 4-메틸시클로헥실기, 2,3-디메틸시클로헥실기, 3,4,5-트리메틸시클로헥실기, 4-tert-부틸시클로헥실기, 시클로헵틸기, 시클로옥틸기 등이 있으나, 이에 한정되지 않는다.In the present invention, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and specifically includes cyclopropyl group, cyclobutyl group, cyclopentyl group, 3-methylcyclopentyl group, 2,3-dimethylcyclopentyl group, Methylcyclohexyl group, 2,3-dimethylcyclohexyl group, 3,4,5-trimethylcyclohexyl group, 4-tert-butylcyclohexyl group, cycloheptyl group, cyclo An octyl group, and the like, but are not limited thereto.

본 발명에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다.In the present invention, examples of the halogen group include fluorine, chlorine, bromine or iodine.

본 발명에 있어서, 플루오레닐기는 2개의 고리 유기화합물이 1개의 원자를 통하여 연결된 구조로서, 예로는

Figure pat00013
등이 있다.In the present invention, a fluorenyl group is a structure in which two cyclic organic compounds are connected via one atom,
Figure pat00013
.

본 발명에 있어서, 플루오레닐기는 열린 플루오레닐기의 구조를 포함하며, 여기서 열린 플루오레닐기는 2개의 고리 유기화합물이 1개의 원자를 통하여 연결된 구조에서 한쪽 고리 화합물의 연결이 끊어진 상태의 구조로서, 예로는

Figure pat00014
등이 있다.In the present invention, a fluorenyl group includes a structure of an open fluorenyl group, wherein an open fluorenyl group is a structure in which one ring compound is disconnected in a structure in which two ring organic compounds are connected via one atom For example,
Figure pat00014
.

본 발명에 있어서, 아릴아민기의 예로는 치환 또는 비치환된 모노아릴아민기, 치환 또는 비치환된 디아릴아민기, 또는 치환 또는 비치환된 트리아릴아민기가 있다. 상기 아릴아민기 중의 아릴기는 단환식 아릴기일 수 있고, 다환식 아릴기일 수 있다. 상기 아릴기가 2 이상을 포함하는 아릴아민기는 단환식 아릴기, 다환식 아릴기, 또는 단환식아릴기와 다환식 아릴기를 동시에 포함할 수 있다.In the present invention, examples of the arylamine group include a substituted or unsubstituted monoarylamine group, a substituted or unsubstituted diarylamine group, or a substituted or unsubstituted triarylamine group. The aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group. The arylamine group having at least two aryl groups may contain a monocyclic aryl group, a polycyclic aryl group, or a monocyclic aryl group and a polycyclic aryl group at the same time.

상기 아릴아민기의 구체적인 예로는 페닐아민기, 나프틸아민기, 비페닐아민기, 안트라세닐아민기, 3-메틸-페닐아민기, 4-메틸-나프틸아민기, 2-메틸-비페닐아민기, 9-메틸-안트라세닐아민기, 디페닐 아민기, 페닐 나프틸 아민기, 디톨릴 아민기, 페닐 톨릴 아민기, 카바졸기 및 트리페닐 아민기 등이 있으나, 이에 한정되는 것은 아니다.Specific examples of the arylamine group include a phenylamine group, a naphthylamine group, a biphenylamine group, an anthracenylamine group, a 3-methylphenylamine group, a 4-methylnaphthylamine group, But are not limited to, an amine group, a 9-methyl-anthracenylamine group, a diphenylamine group, a phenylnaphthylamine group, a ditolylamine group, a phenyltolylamine group, a carbazole group and a triphenylamine group.

본 발명에 있어서, 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다.In the present invention, the silyl group is specifically exemplified by trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, vinyldimethylsilyl, propyldimethylsilyl, triphenylsilyl, diphenylsilyl, But are not limited thereto.

본 발명에 있어서, 헤테로아릴아민기 중의 헤테로 아릴기는 전술한 헤테로고리기의 예시 중에서 선택될 수 있다.In the present invention, the heteroaryl group in the heteroarylamine group can be selected from the examples of the above-mentioned heterocyclic group.

본 발명에 있어서, 알킬티옥시기, 알킬술폭시기 중의 알킬기는 전술한 알킬기의 예시와 같다. 구체적으로 알킬티옥시기로는 메틸티옥시기, 에틸티옥시기, tert-부틸티옥시기, 헥실티옥시기, 옥틸티옥시기 등이 있고, 알킬술폭시기로는 메실, 에틸술폭시기, 프로필술폭시기, 부틸술폭시기 등이 있으나, 이에 한정되지 않는다.
In the present invention, the alkyloxy group in the alkylthio group and the alkyl group in the alkylsulfoxy group are the same as the aforementioned alkyl groups. Specific examples of the alkyloxy group include a methylthio group, an ethylthio group, a tert-butylthio group, a hexylthio group and an octylthio group. Examples of the alkylsulfoxy group include a mesyl group, an ethylsulfoxy group, a propylsulfoxy group, But are not limited thereto.

본 발명에 있어서, '치환 또는 비치환된'이란, 중수소, 할로겐기, 니트릴기, 니트로기, 히드록시기, 알킬기, 시클로알킬기, 알콕시기, 아릴옥시기, 알킬티옥시기, 아릴티옥시기, 알킬술폭시기, 아릴술폭시기, 알케닐기, 실릴기, 붕소기, 알킬아민기, 아랄킬아민기, 아릴아민기, 아릴기, 플루오레닐기, 카바졸기 및 N, O 및 S 원자 중 1개 이상을 포함하는 헤테로고리기 중 적어도 하나의 치환기로 치환 또는 비치환된 것을 의미한다.In the present invention, "substituted or unsubstituted" means a group selected from the group consisting of deuterium, halogen, nitrile, nitro, hydroxy, alkyl, cycloalkyl, , An arylsulfoxy group, an alkenyl group, a silyl group, a boron group, an alkylamine group, an aralkylamine group, an arylamine group, an aryl group, a fluorenyl group, a carbazole group and at least one of N, O and S atoms Substituted or unsubstituted with at least one substituent in the heterocyclic group.

본 발명에 있어서, 치환된 아릴렌기라 함은, 페닐기, 비페닐기, 나프탈렌기, 플루오레닐기, 파이레닐기, 페난트레닐기, 페릴렌기, 테트라세닐기. 안트라센닐기 등이 다른 치환기로 치환된 것을 의미한다.In the present invention, the substituted arylene group means a phenyl group, a biphenyl group, a naphthalene group, a fluorenyl group, a pyrenyl group, a phenanthrenyl group, a perylene group, a tetracenyl group. Anthracenyl group and the like are substituted with other substituents.

본 발명에 있어서, 치환된 헤테로아릴렌기라 함은, 피리딜기, 티오페닐기, 트리아진기, 퀴놀린기, 페난트롤린기, 이미다졸기, 티아졸기, 옥사졸기, 카바졸기 및 이들의 축합헤테로고리기, 예컨대 벤즈퀴놀린기, 벤즈이미다졸기, 벤즈옥사졸기, 벤즈티아졸기, 벤즈카바졸기, 디벤조티오페닐기, 디벤조퓨란기 등이 다른 치환기로 치환된 것을 의미한다.In the present invention, the substituted heteroarylene group includes a pyridyl group, a thiophenyl group, a triazine group, a quinoline group, a phenanthroline group, an imidazole group, a thiazole group, an oxazole group, a carbazole group and condensed heterocyclic groups, Such as a benzoquinoline group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzzcarbazole group, a dibenzothiophenyl group, a dibenzofurane group and the like are substituted with other substituents.

본 발명에 있어서, 상기 [화학식 1] 또는 [화학식 2]의 L1 내지 L4, Ar1, 및 R1 내지 R12는 추가의 치환기로 더 치환될 수 있고, 이들의 예로는 중수소, 할로겐기, 알킬기, 알케닐기, 알콕시기, 실릴기, 아릴알케닐기, 아릴기, 헤테로아릴기, 카바졸기, 아릴아민기, 아릴기로 치환 또는 비치환된 플루오레닐기, 니트릴기 등을 들 수 있으나, 이에만 한정되는 것은 아니다.
In the present invention, L 1 to L 4 , Ar 1 , and R 1 to R 12 of the above-mentioned formula (1) or (2) may further be substituted with further substituents. Examples thereof include deuterium, A fluorenyl group or a nitrile group substituted or unsubstituted with an alkyl group, an alkenyl group, an alkoxy group, a silyl group, an arylalkenyl group, an aryl group, a heteroaryl group, a carbazole group, an arylamine group, an aryl group, But is not limited thereto.

상기 [화학식 1] 또는 [화학식 2]로 표시되는 본 발명에 따른 유기발광 화합물은 그 구조적 특이성으로 인하여 유기전계발광소자의 유기물층으로 사용될 수 있고, 보다 구체적으로 유기물층 내의 발광층에 호스트 화합물 및/또는 도판트 화합물로 사용될 수 있다.The organic luminescent compound according to the present invention represented by the above Chemical Formula 1 or 2 can be used as an organic material layer of an organic electroluminescent device due to its structural specificity. More specifically, a host compound and / Can be used.

특히, [화학식 1]로 표시되는 유기발광 화합물은 발광층의 호스트 화합물로서, [화학식 2]로 표시되는 유기발광 화합물은 발광층의 도펀트 화합물로 채용될 수 있다.In particular, the organic luminescent compound represented by the formula (1) is a host compound in the luminescent layer, and the organic luminescent compound represented by the formula (2) can be employed as a dopant compound in the luminescent layer.

본 발명에 따른 [화학식 1]로 표시되는 화합물의 바람직한 구체예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.Preferred examples of the compound represented by the formula (1) according to the present invention include, but are not limited to, the following compounds.

Figure pat00015
Figure pat00015

Figure pat00016
Figure pat00016

Figure pat00017
Figure pat00017

Figure pat00018
Figure pat00018

Figure pat00019
Figure pat00019

Figure pat00020

Figure pat00020

또한, 본 발명에 따른 [화학식 1]로 표시되는 화합물의 바람직한 다른 구체예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.Further, other preferred specific examples of the compound represented by the formula (1) according to the present invention include, but are not limited to, the following compounds.

Figure pat00021
Figure pat00021

Figure pat00022
Figure pat00022

Figure pat00023
Figure pat00023

Figure pat00024
Figure pat00024

Figure pat00025
Figure pat00025

Figure pat00026
Figure pat00026

Figure pat00027
Figure pat00027

Figure pat00028
Figure pat00028

Figure pat00029
Figure pat00029

Figure pat00030
Figure pat00030

Figure pat00031
Figure pat00031

Figure pat00032

Figure pat00032

또한, 본 발명에 따른 [화학식 2]로 표시되는 화합물의 바람직한 구체예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.In addition, preferred specific examples of the compound represented by the formula (2) according to the present invention include, but are not limited to, the following compounds.

Figure pat00033
Figure pat00033

Figure pat00034
Figure pat00034

Figure pat00035
Figure pat00035

Figure pat00036
Figure pat00036

Figure pat00037

Figure pat00037

또한, 본 발명에 따른 [화학식 2]로 표시되는 화합물의 바람직한 다른 구체예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.Other preferred examples of the compound represented by the formula (2) according to the present invention include, but are not limited to, the following compounds.

Figure pat00038
Figure pat00038

Figure pat00039
Figure pat00039

Figure pat00040
Figure pat00040

Figure pat00041
Figure pat00041

Figure pat00042
Figure pat00042

Figure pat00043
Figure pat00043

Figure pat00044
Figure pat00044

Figure pat00045
Figure pat00045

Figure pat00046
Figure pat00046

Figure pat00047
Figure pat00047

Figure pat00048
Figure pat00048

Figure pat00049
Figure pat00049

Figure pat00050
Figure pat00050

Figure pat00051
Figure pat00051

Figure pat00052
Figure pat00052

Figure pat00053
Figure pat00053

Figure pat00054
Figure pat00054

Figure pat00055
Figure pat00055

Figure pat00056
Figure pat00056

Figure pat00057
Figure pat00057

Figure pat00058
Figure pat00058

Figure pat00059
Figure pat00059

Figure pat00060
Figure pat00060

Figure pat00061

Figure pat00061

상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 도입된 치환기의 고유 특성을 갖는 유기발광 화합물을 합성할 수 있다. 예컨대, 유기전계발광소자의 제조시 사용되는 정공 주입층 물질, 정공 수송층 물질, 발광층 물질, 및 전자 수송층 물질에 사용되는 치환기를 상기 구조에 도입함으로써 각 유기물층에서 요구하는 조건들을 충족시키는 물질을 제조할 수 있다. 본 발명의 화합물은 유기전계발광소자의 통상의 제조방법에 따라 소자에 적용할 수 있다.An organic luminescent compound having the intrinsic characteristics of the substituent introduced by introducing various substituents into the core structure having the above structure can be synthesized. For example, by introducing a substituent used in a hole injecting layer material, a hole transporting layer material, a light emitting layer material, and an electron transporting layer material used in manufacturing an organic electroluminescent device into the structure, a material meeting the requirements of each organic material layer is manufactured . The compound of the present invention can be applied to a device according to a conventional method of manufacturing an organic electroluminescent device.

본 발명의 하나의 실시예에 따른 유기전계발광소자는 제1 전극과 제2 전극 및 이 사이에 배치된 유기물층을 포함하는 구조로 이루어질 수 있으며, 본 발명에 따른 유기발광 화합물을 소자의 유기물층에 사용한다는 것을 제외하고는 통상의 소자의 제조 방법 및 재료를 사용하여 제조될 수 있다.
The organic electroluminescent device according to one embodiment of the present invention may have a structure including a first electrode, a second electrode and an organic material layer disposed therebetween, and the organic electroluminescent compound according to the present invention may be used for an organic material layer And can be manufactured using conventional device manufacturing methods and materials.

본 발명에 따른 유기전계발광소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등을 포함하는 구조를 가질 수 있다. 그러나, 이에 한정되지 않고 더 적은 수의 유기물층을 포함할 수도 있다.The organic material layer of the organic electroluminescent device according to the present invention may have a single layer structure, but may have a multilayer structure in which two or more organic material layers are stacked. For example, a structure including a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer. However, it is not limited to this and may include a smaller number of organic layers.

따라서, 본 발명에 따른 유기전계발광소자에서, 상기 유기물층은 정공 주입층, 정공 수송층, 및 정공 주입 및 정공 수송을 동시에 하는 층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물을 포함할 수 있다.Therefore, in the organic electroluminescent device according to the present invention, the organic material layer may include at least one of a hole injecting layer, a hole transporting layer, and a layer simultaneously injecting holes and transporting holes, May include a compound represented by formula (1) or (2).

또한, 상기 유기물층은 발광층을 포함할 수 있고, 상기 발광층이 상기 [화학식 1]로 표시되는 화합물을 포함할 수 있다. 여기서, 상기 [화학식 1]로 표시되는 화합물은 발광층 내 호스트 물질로서 포함될 수 있다. 상기 [화학식 1]로 표시되는 화합물이 발광층 내 호스트 물질로서 포함되는 경우에, 상기 발광층은 상기 [화학식 2]로 표시되는 화합물을 포함하는 1종 이상의 도펀트를 포함할 수 있다.Further, the organic material layer may include a light emitting layer, and the light emitting layer may include a compound represented by the general formula (1). Here, the compound represented by Formula 1 may be included as a host material in the light emitting layer. When the compound represented by the formula (1) is contained as a host material in the light emitting layer, the light emitting layer may include at least one dopant including the compound represented by the formula (2).

또한, 상기 유기물층은 발광층을 포함할 수 있고, 상기 발광층이 상기 [화학식 2]로 표시되는 화합물을 포함할 수 있다. 여기서, 상기 [화학식 2]로 표시되는 화합물은 발광층 내 도펀트 물질로서 포함될 수 있다. 상기 [화학식 2]로 표시되는 화합물이 발광층 내 도펀트 물질로서 포함되는 경우에, 상기 발광층은 상기 [화학식 1]로 표시되는 화합물을 포함하는 1종 이상의 호스트 물질을 포함할 수 있다.
Further, the organic material layer may include a light emitting layer, and the light emitting layer may include a compound represented by the general formula (2). Here, the compound represented by Formula 2 may be included as a dopant in the light emitting layer. When the compound represented by Formula 2 is included as a dopant in the light emitting layer, the light emitting layer may include at least one host material including a compound represented by Formula 1.

이와 같은 다층 구조의 유기물층에서 상기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물은 발광층, 정공 주입/정공 수송과 발광을 동시에 하는 층, 정공 수송과 발광을 동시에 하는 층, 또는 전자 수송과 발광을 동시에 하는 층 등에 포함될 수 있다.In the organic compound layer having such a multi-layer structure, the compound represented by the formula (1) or (2) may be used as a light emitting layer, a layer that simultaneously transports holes and holes, a layer that simultaneously transports holes and emits light, And the like.

예컨대, 본 발명에 따른 유기 전자 소자의 구조는 도 1 내지 5에 예시되어 있다.For example, the structure of an organic electronic device according to the present invention is illustrated in Figs.

도 1에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.1 shows an organic electroluminescent device 1 in which an anode 2, a hole injecting layer 3, a hole transporting layer 4, a light emitting layer 5, an electron transporting layer 6 and a cathode 7 are sequentially laminated on a substrate 1 Are illustrated. In such a structure, the compound represented by Formula 1 or Formula 2 may be included in the hole injection layer 3, the hole transport layer 4, the light emitting layer 5, or the electron transport layer 6.

도 2에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4) 또는 전자 수송층(6)에 포함될 수 있다.2 shows a structure of an organic electroluminescent device in which an anode 2, a hole injecting layer 3, a hole transporting layer 4, a light emitting layer 5 and a cathode 7 are sequentially laminated on a substrate 1 . In such a structure, the compound represented by Formula 1 or Formula 2 may be included in the hole injecting layer 3, the hole transporting layer 4, or the electron transporting layer 6.

도 3에는 기판(1) 위에 양극(2), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물은 상기 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.3 illustrates the structure of an organic electroluminescent device in which an anode 2, a hole transport layer 4, a light emitting layer 5, an electron transport layer 6, and a cathode 7 are sequentially laminated on a substrate 1. In such a structure, the compound represented by the formula (1) or (2) may be included in the hole transport layer (4), the light emitting layer (5), or the electron transport layer (6).

도 4에는 기판(1) 위에 양극(2), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물은 상기 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.4 shows the structure of an organic electroluminescent device in which an anode 2, a light emitting layer 5, an electron transport layer 6 and a cathode 7 are sequentially laminated on a substrate 1. [ In such a structure, the compound represented by the formula (1) or (2) may be included in the light emitting layer (5) or the electron transport layer (6).

도 5에는 기판(1) 위에 양극(2), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기전계발광소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물은 상기 발광층(5)에 포함될 수 있다.5 illustrates the structure of an organic electroluminescent device in which an anode 2, a light-emitting layer 5, and a cathode 7 are sequentially laminated on a substrate 1. As shown in FIG. In such a structure, the compound represented by the formula (1) or (2) can be included in the luminescent layer (5).

예컨대, 본 발명에 따른 유기전계발광소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층, 전자 수송층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다.For example, the organic electroluminescent device according to the present invention can be manufactured by using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation to form a metal oxide or a conductive metal oxide on the substrate, An anode is formed by depositing an alloy on the anode, and an organic material layer including a hole injecting layer, a hole transporting layer, a light emitting layer, and an electron transporting layer is formed on the anode, and then a substance usable as a cathode is deposited thereon.

이와 같은 방법 외에도, 기판상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기전계발광소자를 만들 수도 있다. 상기 유기물층은 정공 주입층, 정공 수송층, 발광층 및 전자 수송층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 솔벤트 프로세스(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다.In addition to such a method, an organic electroluminescent device may be formed by sequentially depositing a cathode material, an organic material layer, and a cathode material on a substrate. The organic material layer may have a multi-layer structure including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer, but is not limited thereto and may have a single layer structure. In addition, the organic material layer may be formed using a variety of polymer materials by a solvent process such as a spin coating process, a dip coating process, a doctor blading process, a screen printing process, an inkjet printing process or a thermal transfer process, Layer.

상기 양극 물질로는 통상 유기물층으로 정공주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금, 아연 산화물, 인듐 산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물, ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the anode material, a material having a large work function is preferably used so that hole injection can be smoothly conducted into the organic material layer. Specific examples of the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof, zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO) metal oxides, ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT) , Conductive polymers such as polypyrrole and polyaniline, but are not limited thereto.

상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금, LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.The negative electrode material is preferably a material having a small work function to facilitate electron injection into the organic material layer. Specific examples of the negative electrode material include a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or an alloy thereof, a multilayer such as LiF / Al or LiO 2 / Structural materials, and the like, but are not limited thereto.

정공 주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입받을 수 있는 물질로서, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴 헥사아자트리페닐렌, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole injecting material, it is preferable that the highest occupied molecular orbital (HOMO) of the hole injecting material be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injecting material include metal porphyrine, oligothiophene, arylamine-based organic materials, hexanitrile hexaazatriphenylene, quinacridone-based organic materials, perylene-based organic materials, Anthraquinone, polyaniline and a polythiophene-based conductive polymer, but are not limited thereto.

정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송 받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole transporting material, a material capable of transporting holes from the anode or the hole injection layer to the light emitting layer and having high mobility to holes is suitable. Specific examples include arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion together, but are not limited thereto.

발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3), 카르바졸 계열 화합물, 이량체화 스티릴(dimerized styryl) 화합물, BAlq, 10-히드록시벤조 퀴놀린-금속 화합물, 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물, 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자, 스피로(spiro) 화합물, 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The light emitting material is preferably a material capable of emitting light in the visible light region by transporting and combining holes and electrons from the hole transporting layer and the electron transporting layer, respectively, and having a high quantum efficiency for fluorescence or phosphorescence. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ), carbazol-based compounds, dimerized styryl compounds, BAlq, 10-hydroxybenzoquinoline-metal compounds, benzoxazole, benzthiazole and A benzimidazole-based compound, a poly (p-phenylene vinylene) (PPV) -based polymer, a spiro compound, polyfluorene, rubrene, and the like.

전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물, Alq3를 포함한 착물, 유기 라디칼 화합물, 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다.
As the electron transporting material, a material capable of transferring electrons from the cathode well into the light emitting layer, which is highly mobile, is suitable. Specific examples thereof include, but are not limited to, an Al complex of 8-hydroxyquinoline, a complex containing Alq 3 , an organic radical compound, and a hydroxyflavone-metal complex.

본 발명에 따른 유기전계발광소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic electroluminescent device according to the present invention may be a front emission type, a back emission type, or a both-sided emission type, depending on the material used.

또한, 본 발명에 따른 유기발광 화합물은 유기 태양 전지, 유기 감광체, 유기 트랜지스터 등을 비롯한 유기 전자 소자에서도 유기전계발광소자에 적용되는 것과 유사한 원리로 작용할 수 있다.
In addition, the organic electroluminescent compound according to the present invention can act on a principle similar to that applied to an organic electroluminescent device in an organic electronic device including an organic solar cell, an organophotoreceptor, an organic transistor and the like.

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나, 하기의 실시예는 본 발명을 예시하기 위한 것이며, 이에 의하여 본 발명의 범위가 한정되는 것은 아니다.
Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are intended to illustrate the invention and are not intended to limit the scope of the invention.

합성예 1 : [화합물 1]의 합성Synthesis Example 1: Synthesis of [Compound 1]

(1) [중간체 1-0]의 합성(1) Synthesis of [intermediate 1-0]

Figure pat00062
Figure pat00062

9-bromoanthracene(5.0 g, 0.019 mol)에 oxalyl dichloride(2.9 g, 0.022 mol), Pd(dba)2(0.9 g, 0.0010 mol), sodium-tert-butoxide(3.7 g, 0.038 mol)에 톨루엔 100 mL를 넣고 95 ℃에서 4시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 [중간체 1-0]을 4.1g(70%) 수득하였다.(m/z=311)
100 mL of toluene was added to 9-bromoanthracene (5.0 g, 0.019 mol), oxalyl dichloride (2.9 g, 0.022 mol), Pd (dba) 2 (0.9 g, 0.0010 mol) and sodium tert- And the mixture was reacted at 95 ° C for 4 hours with stirring. After completion of the reaction, the reaction mixture was cooled, and the product was separated into H 2 O: MC and column-purified (n-hexane: MC) to obtain 4.1 g (70%) of [intermediate 1-0]

(2) [중간체 1-1]의 합성(2) Synthesis of [intermediate 1-1]

Figure pat00063
Figure pat00063

[중간체 1-0](5.0 g, 0.016 mol), phenylmagnesium bromide(7.0 g, 0.037 mol)에 THF 100 mL를 넣고 -78 ℃에서 5시간 교반하여 반응시켰다. 반응종료 후H20 : MC에 층분리 후 컬럼정제(n-HEXANE : MC)하여 [중간체 1-1]을 6.7g (90%)수득하였다 (m/z =467)
100 mL of THF was added to a solution of [Intermediate 1-0] (5.0 g, 0.016 mol) and phenylmagnesium bromide (7.0 g, 0.037 mol) and the mixture was reacted at -78 ° C for 5 hours with stirring. After completion of the reaction H 2 0: after separation layer MC and column purification (n-HEXANE: MC) to a [Intermediate 1-1 was obtained 6.7g (90%) (m / z = 467)

(3) [중간체 1-2]의 합성(3) Synthesis of [intermediate 1-2]

Figure pat00064
Figure pat00064

[중간체 1-1](5.0 g, 0.010 mol), Mg(0.6 g, 0.024 mol), Pd(dba)2(0.5 g, 0.00 5mol), ammonium acetate(1.6 g, 0.020 mol)에 MeOH 100 mL를 넣고 25 ℃에서 6시간 교반하여 반응시켰다. 반응 종료 후 H2O : MC에 층분리 후 컬럼정제(n-HEXANE : MC)하여 [중간체 1-2]를 3.9g(90%)수득하였다 (m/z=435)
100 mL of MeOH was added to a solution of [Intermediate 1-1] (5.0 g, 0.010 mol), Mg (0.6 g, 0.024 mol), Pd (dba) 2 (0.5 g, 0.005 mol) Followed by stirring at 25 ° C for 6 hours. After completion of the reaction, the reaction mixture was separated into H 2 O: MC and purified by column (n-HEXANE: MC) to obtain 3.9 g (90%) of [intermediate 1-2]

(4) [중간체 1-3]의 합성(4) Synthesis of [intermediate 1-3]

Figure pat00065
Figure pat00065

1-bromonaphthalene(2.5 g, 0.012 mol)에 1,4-phenylenediboronic acid(2.2 g, 0.013 mol), Pd(pph3)4(0.6 g, 0.0006 mol), potassium carbonate(3.0 g, 0.022 mol)에 THF 100 mL를 넣고 65 ℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 [중간체 1-3]을3.8g(72%)수득하였다.(m/z=248.08)
To a mixture of 1,4-phenylenediboronic acid (2.2 g, 0.013 mol), Pd (pph 3 ) 4 (0.6 g, 0.0006 mol) and potassium carbonate (3.0 g, 0.022 mol) in 1-bromonaphthalene (2.5 g, 0.012 mol) And the mixture was reacted at 65 占 폚 for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and column-purified (n-hexane: MC) to obtain 3.8 g (72%) of [intermediate 1-3]

(5) [화합물 1]의 합성(5) Synthesis of [Compound 1]

Figure pat00066
Figure pat00066

[중간체 1-2] (5.0 g, 0.011 mol)에 [중간체 1-3](2.97 g, 0.012 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 1] 3.9g (수율 70%)을 얻었다.[Compound 1] was synthesized by the same method as in Synthesis Example 1- (4), except that [Intermediate 1-3] (2.97 g, 0.012 mol) was added to the intermediate 1-2 [5.0 g, 0.011 mol] (Yield: 70%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 8.01/d, 7.88/d, 7.75/d, 7.61/m, 7.38/m, 7.36/m, 7.26/m, 7.17/d) 2H(7.55/m, 7.27/m, 5.00/s) 4H(7.40/m, 7.29/d, 7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / d, 8.01 / d, 7.88 / d, 7.75 / d, 7.61 / m, 7.38 / m 7.26 / m, 7.27 / d) 2H (7.55 / m, 7.27 / m, 5.00 / s) 4H (7.40 /

LC/MS: m/z= 559[(M+1)+]
LC / MS: m / z = 559 [(M + 1) < + &

합성예 2 : [화합물 12]의 합성Synthesis Example 2: Synthesis of [Compound 12]

(1) [중간체 12-1]의 합성(1) Synthesis of [intermediate 12-1]

Figure pat00067
Figure pat00067

4-bromonaphthalen-1-ylboronic acid(5.0 g, 0.011 mol)에 4-bromonaphthalen-1-ylboronic acid(3.3 g, 0.013 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 12-1] 4.6g (수율 72%)을 얻었다.(m/z=298.14)
4-bromonaphthalen-1-ylboronic acid (5.0 g, 0.011 mol) was added to 4-bromonaphthalen-1-ylboronic acid (3.3 g, 0.013 mol) 12-1] (m / z = 298.14) (yield: 72%).

(2) [화합물 12]의 합성(2) Synthesis of [Compound 12]

Figure pat00068
Figure pat00068

[중간체 1-2](5.0 g, 0.011 mol)에 [중간체 12-1](5.0 g, 0.009 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 12] 3.8g (수율 70%)을 얻었다.[Compound 12] was synthesized in the same manner as in Synthesis Example 1- (4), except that [Intermediate 12-1] (5.0 g, 0.009 mol) was added to [Intermediate 1-2] (5.0 g, 0.011 mol) (Yield: 70%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.92/d, 7.88/d, 7.75/d, 7.73/d, 7.58/d, 7.38/m, 7.36/m, 7.26/m, 7.17/d) 2H(8.55/d, 8.00/d, 7.59/m, 7.55/m, 7.27/m, 5.00/s) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.92 / d, 7.88 / d, 7.75 / d, 7.73 / d, 7.58 / d, 7.38 / m, 7.36 / m, 7.26 / m, 7.17 / d ) 2H (8.55 / d, 8.00 / d, 7.59 / m, 7.55 / m, 7.27 /

LC/MS: m/z= 609[(M+1)+]
LC / MS: m / z = 609 [(M + 1) < + &

합성예 3 : [화합물 29]의 합성Synthesis Example 3: Synthesis of [Compound 29]

(1) [중간체 12-2]의 합성(1) Synthesis of [Intermediate 12-2]

Figure pat00069
Figure pat00069

naphthalene-1,4-diyldiboronic acid(5.0 g, 0.011 mol)에 2-bromo-9,9-dimethyl-9H-fluorene(2.45 g, 0.009 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 12-2] 4.2g (수율 69%)을 얻었다.(m/z : 364.24)
bromo-9,9-dimethyl-9H-fluorene (2.45 g, 0.009 mol) was added to naphthalene-1,4-diyldiboronic acid (5.0 g, 0.011 mol) To obtain 4.2 g (yield 69%) of [intermediate 12-2] (m / z: 364.24)

(2) [화합물 29]의 합성(2) Synthesis of [Compound 29]

Figure pat00070
Figure pat00070

[중간체 1-2](5.0 g, 0.011 mol)에 [중간체 12-2](4.8 g, 0.0132 mol)을 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 29] 4.2g (수율 69%)을 얻었다.(m/z : 674.87)[Compound 29] was obtained by synthesizing [Intermediate 12-2] (4.8 g, 0.0132 mol) in [Intermediate 1-2] (5.0 g, 0.011 mol) (Yield: 69%). (M / z: 674.87)

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.93/d, 7.88/d, 7.87/d, 7.77/s, 7.75/d, 7.63/d, 7.36/m, 7.28/m, 7.26/m, 7.17/d) 2H(8.55/d, 7.38/m, 7.27/m, 5.00/s, 1.72/s) 3H(8.01/d, 7.55/d) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.93 / d, 7.88 / d, 7.87 / d, 7.77 / s, 7.75 / d, 7.63 / d, 7.36 / m, 7.28 / m, 7.26 / m D, 7.57 / d) 2H (8.55 / d, 7.38 / m, 7.27 / m, 5.00 / s, 1.72 / s)

LC/MS: m/z= 675[(M+1)+]
LC / MS: m / z = 675 [(M + 1) < + &

합성예 4 : [화합물 36]의 합성Synthesis Example 4: Synthesis of [Compound 36]

(1) [중간체 36-1]의 합성(1) Synthesis of [Intermediate 36-1]

Figure pat00071
Figure pat00071

9,9-dimethyl-9H-fluorene-2,7-diyldiboronic acid(5.0 g, 0.011 mol)에 9-bromophenanthrene(2.3 g, 0.009 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 36-1] 4.7g (수율 72%)을 얻었다.(m/z=414.3)
9-bromophenanthrene (2.3 g, 0.009 mol) was added to 9,9-dimethyl-9H-fluorene-2,7-diyldiboronic acid (5.0 g, 0.011 mol) To obtain 4.7 g (yield 72%) of [intermediate 36-1]. (M / z = 414.3)

(2) [화합물 36]의 합성(2) Synthesis of [Compound 36]

Figure pat00072
Figure pat00072

[중간체 36-1](5.0 g, 0.012 mol)에 [중간체 1-2](4.3 g, 0.010 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 36] 3.8g (수율 74%)을 얻었다.(m/z=476)[Compound 36] was synthesized in the same manner as in Synthesis Example 1- (4), except that [Intermediate 1-2] (4.3 g, 0.010 mol) was added to the intermediate 36-1 (5.0 g, 0.012 mol) (Yield: 74%). (M / z = 476)

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.01/d, 7.88/d, 7.75/d, 7.38/m, 7.36/m, 7.26/m, 7.17/d) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 7.77/s, 7.63/d, 7.27/m, 5.00/s, 1.72/s) 3H(7.93/d) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.01 / d, 7.88 / d, 7.75 / d, 7.38 / m, 7.36 / m, 7.26 / m, 7.17 / d) 2H (8.93 / d, 8.12 d, 7.88 / m, 7.82 / 7.77 / s, 7.63 / d, 7.27 / m, 5.00 / s, 1.72 / s)

LC/MS: m/z= 725[(M+1)+]
LC / MS: m / z = 725 [(M + 1) < + &

합성예 5 : [화합물 52]의 합성Synthesis Example 5: Synthesis of [Compound 52]

(1) [중간체 52-1]의 합성(1) Synthesis of [Intermediate 52-1]

Figure pat00073
Figure pat00073

naphthalen-1-ylboronic acid(5.0 g, 0.029 mol)에 4-bromo-2,5-dimethylphenylboronic acid(6.6 g, 0.029 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 52-1] 4.2g (수율 71%)을 얻었다. (m/z=276.14.2)
4-bromo-2,5-dimethylphenylboronic acid (6.6 g, 0.029 mol) was added to naphthalen-1-ylboronic acid (5.0 g, 0.029 mol) in the same manner as in Synthesis Example 1- 52-1] (yield: 71%). (m / z = 276.14. 2)

(2) [화합물 52]의 합성(2) Synthesis of [Compound 52]

Figure pat00074
Figure pat00074

[중간체 1-2](5.0 g, 0.009 mol)에 2,5-dimethyl-4-(naphthalen-1-yl)phenylboronic acid(3.03 g, 0.011 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 52] 3.9g (수율 73%)을 얻었다.(m/z=476)4-naphthalen-1-yl) phenylboronic acid (3.03 g, 0.011 mol) was added to the intermediate 1-2 [5.0 g, 0.009 mol] (M / z = 476) of [Compound 52] (yield 73%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 8.01/d, 7.88/d, 7.75/d, 7.61/m, 7.38/m, 7.36/m, 7.26/m, 7.17/d) 2H(7.73/d, 7.55/m, 7.27/m, 5.00/s, 2.59/s) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / d, 8.01 / d, 7.88 / d, 7.75 / d, 7.61 / m, 7.38 / m (7.36 / m, 7.26 / 7.17 / d) 2H (7.73 / d, 7.55 / m, 7.27 / m, 5.00 / s, 2.59 / s)

LC/MS: m/z= 587[(M+1)+]
LC / MS: m / z = 587 [(M + 1) < + &

합성예 6 : [화합물 65]의 합성Synthesis Example 6: Synthesis of [Compound 65]

(1) [중간체 65-1]의 합성(1) Synthesis of [intermediate 65-1]

Figure pat00075
Figure pat00075

[중간체 1-0](5.0 g, 0.016 mol)에 naphthalen-2-ylmagnesium bromide(8.5 g, 0.037 mol)(1.9 g, 0.011 mol)를 넣고 합성예 1-(2)에서 사용된 동일한 방법으로 합성하여 [중간체 65-1] 8.3g (수율91%)을 얻었다.(m/z=567)
Synthesis of naphthalen-2-ylmagnesium bromide (8.5 g, 0.037 mol) (1.9 g, 0.011 mol) was added to the intermediate 1-0 (5.0 g, 0.016 mol) 8.3 g (yield: 91%) of [intermediate 65-1] was obtained. (M / z = 567)

(2) [중간체 65-2]의 합성(2) Synthesis of [Intermediate 65-2]

Figure pat00076
Figure pat00076

[중간체 6-1](5.0 g, 0.009 mol)를 합성예 1-(3)에서 사용된 동일한 방법으로 합성하여 [중간체 65-2] 4.5g (수율93%)을 얻었다.(m/z=535)
[Synthesis of Intermediate 6-1] (5.0 g, 0.009 mol) was synthesized in the same manner as in Synthesis Example 1- (3) to give 4.5 g (yield 93% 535)

(3) [중간체 65-3]의 합성(3) Synthesis of [Intermediate 65-3]

Figure pat00077
Figure pat00077

4-bromophenylboronic acid(5.0 g, 0.025 mol)에 naphthalen-1-ylboronic acid(4.2 g, 0.025 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 65-3] 3.9g (수율 76%)을 얻었다.(m/z=248.08)
Synthesis was conducted in the same manner as in Synthesis Example 1- (4), except that naphthalen-1-ylboronic acid (4.2 g, 0.025 mol) was added to 4-bromophenylboronic acid (5.0 g, 0.025 mol) (Yield: 76%). (M / z = 248.08)

(4) [화합물 65]의 합성(4) Synthesis of [Compound 65]

Figure pat00078
Figure pat00078

[중간체 65-2](5.0 g, 0.009 mol)에 [중간체 65-3](2.67 g, 0.010 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 65] 3.4g (수율 73%)을 얻었다.[Compound 65] was synthesized by the same method as in Synthesis Example 1- (4), except that [Intermediate 65-3] (2.67 g, 0.010 mol) was added to [Intermediate 65-2] (5.0 g, 0.009 mol) (Yield: 73%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 8.01/d, 7.88/d, 7.75/d, 7.61/m, 7.38/m, 7.36/m, 7.26/m, 7.17/d) 2H(8.18/d, 8.05/d, 7.92/d, 7.55/m, 7.54/m, 7.52/m, 7.42/m, 7.00/d, 5.00/s) 4H(7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / d, 8.01 / d, 7.88 / d, 7.75 / d, 7.61 / m, 7.38 / m M, 7.56 / m, 7.42 / m, 7.00 / d, 5.00 / s, ) 4H (7.25 / d)

LC/MS: m/z= 659[(M+1)+]
LC / MS: m / z = 659 [(M + 1) < + &

합성예 7 : [화합물 75]의 합성Synthesis Example 7: Synthesis of [Compound 75]

(1) [중간체 75-1]의 합성(1) Synthesis of [Intermediate 75-1]

Figure pat00079
Figure pat00079

[중간체 1-0](5.0 g, 0.016 mol)에 (4-(trimethylsilyl)phenyl)magnesium bromide(9.4 g, 0.037 mol)(1.9 g, 0.011 mol)를 넣고 합성예 1-(2)에서 사용된 동일한 방법으로 합성하여 [중간체 75-1] 8.3g (수율85%)을 얻었다.(m/z=611)
(1.9 g, 0.011 mol) (4- (trimethylsilyl) phenyl) magnesium bromide (9.4 g, 0.037 mol) was added to a solution of the intermediate 1-0 (5.0 g, 0.016 mol) (M / z = 611) of [Intermediate 75-1] was obtained by the same method as in the synthesis of Intermediate 75-1 (yield: 85%).

(2) [중간체 75-2]의 합성(2) Synthesis of [Intermediate 75-2]

Figure pat00080
Figure pat00080

[중간체 75-1](5.0 g, 0.008 mol)를 합성예 1-(3)에서 사용된 동일한 방법으로 합성하여 [중간체 75-2] 4.0g (수율86%)을 얻었다.(m/z=579)
[Intermediate 75-1] (5.0 g, 0.008 mol) was synthesized in the same manner as in Synthesis Example 1- (3) to give 4.0 g (yield 86% 579)

(3) [중간체 75-3]의 합성(3) Synthesis of [Intermediate 75-3]

Figure pat00081
Figure pat00081

4-bromophenylboronic acid(5.0 g, 0.025 mol)에 9-bromophenanthrene(6.42 g, 0.025 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 75-3] 4.1g (수율 74%)을 얻었다.(m/z=298.14)
4.1 g (yield: 74%) was obtained by synthesizing 9-bromophenanthrene (6.42 g, 0.025 mol) in 4-bromophenylboronic acid (5.0 g, 0.025 mol) in the same manner as in Synthesis Example 1- %). (M / z = 298.14)

(4) [화합물 75]의 합성(4) Synthesis of [Compound 75]

Figure pat00082
Figure pat00082

[중간체 75-2](5.0 g, 0.008 mol)에 [중간체 75-3](2.8 g, 0.009 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 75] 3.8g (수율 72%)을 얻었다.[Compound 75-3] (2.8 g, 0.009 mol) was added to [Intermediate 75-2] (5.0 g, 0.008 mol) in the same manner as in Synthesis Example 1- (4) (Yield: 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.01/d, 7.93/d, 7.88/d, 7.75/d, 7.38/m, 7.36/m, 7.26/d, 7.17/d) 2H(8.93/d, 8.12/d, 7.88/m, 7.82/m, 5.00/s) 4H(7.35/d, 7.27/d, 7.25/d) 6H(0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.01 / d, 7.93 / d, 7.88 / d, 7.75 / d, 7.38 / m, 7.36 / m, 7.26 / d, 7.17 / d) 2H (8.93 d, 7.27 / d, 7.25 / d) 6H (0.25 / s)

LC/MS: m/z= 754[(M+1)+]
LC / MS: m / z = 754 [(M + 1) < + &

합성예 8 : [화합물 18]의 합성Synthesis Example 8: Synthesis of [Compound 18]

(1) [중간체 18-1]의 합성(1) Synthesis of [intermediate 18-1]

Figure pat00083
Figure pat00083

[중간체 1-2](5.0 g, 0.011 mol)에 bis(pinacolato)dibron(3.6 g, 0.014 mol), PdCl2(dppf)(0.4 g, 0.0006 mol), potassium-acetate(3.7 g, 0.036 mol)에 1,4-dioxane 100 mL를 넣고 95 ℃에서 24시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제 (n-Hexane : MC)하여 [중간체 18-1]를 3.8g(71%) 수득하였다. (m/z=482)
Bis (pinacolato) dibron (3.6 g, 0.014 mol), PdCl 2 (dppf) (0.4 g, 0.0006 mol), potassium acetate (3.7 g, 0.036 mol) Was added 100 mL of 1,4-dioxane, and the mixture was reacted at 95 DEG C for 24 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 3.8 g (71%) of [Intermediate 18-1]. (m / z = 482)

(2) [중간체 18-2]의 합성(2) Synthesis of [Intermediate 18-2]

Figure pat00084
Figure pat00084

1,5-dibromonaphthalene(5.0 g, 0.010 mol)에 (3,5-Diphenylphenyl)boronic acid(3.0 g, 0.011 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 18-2] 3.7g (수율 74%)을 얻었다.(m/z=435.35)
(3,5-Diphenylphenyl) boronic acid (3.0 g, 0.011 mol) was added to 1,5-dibromonaphthalene (5.0 g, 0.010 mol) 2] (yield: 74%). (M / z = 435.35)

(3) [화합물 18]의 합성(3) Synthesis of [Compound 18]

Figure pat00085
Figure pat00085

[중간체 18-1](5.0 g, 0.011 mol)에 [중간체 18-2](4.7 g, 0.011 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 18] 4.6g (수율 72%)을 얻었다.[Compound 18-2] (4.7 g, 0.011 mol) was added to [Intermediate 18-1] (5.0 g, 0.011 mol) and the compound [18] was synthesized in the same manner as in Synthesis Example 1- (Yield: 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.01/d, 7.88/d, 7.75/d, 7.38/m, 7.36/m, 7.26/m, 7.17/d) 2H(8.51/d, 8.42/d, 7.61/m, 7.41/m, 7.27/m, 5.00/s) 3H(7.66/s) 4H(7.52/d, 7.51/m, 7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.01 / d, 7.88 / d, 7.75 / d, 7.38 / m, 7.36 / m, 7.26 / m, 7.17 / d) 2H (8.51 / d, 8.42 7.51 / m, 7.27 / m, 5.00 / s) 3H (7.66 /

LC/MS: m/z=711[(M+1)+]
LC / MS: m / z = 711 [(M + 1) < + &

합성예 9 : [화합물 104]의 합성Synthesis Example 9: Synthesis of [Compound 104]

Figure pat00086
Figure pat00086

[중간체 18-2](5.0 g, 0.009 mol)에 9,9-dimethyl-9H-fluoren-2-ylboronic acid(3.0 g, 0.011 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 104] 4.3g (수율 71%)을 얻었다.9,9-dimethyl-9H-fluoren-2-ylboronic acid (3.0 g, 0.011 mol) was added to the intermediate [18-2] (5.0 g, 0.009 mol) in the same manner as in Synthesis Example 1- (4) To obtain 4.3 g (yield: 71%) of [Compound 104].

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.01/d, 7.93/d, 7.88/d, 7.87/d, 7.77/s, 7.75/s, 7.63/d, 7.55/d, 7.36/m, 7.28/m, 7.26/m, 7.17/d) 2H(8.51/d, 8.42/d, 7.61/m, 7.38/m, 7.27/m, 5.00/s, 1.72/s) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.01 / d, 7.93 / d, 7.88 / d, 7.87 / d, 7.77 / s, 7.75 / s, 7.63 / d, 7.55 / d, 7.36 / m M, 7.27 / d) 2H (8.51 / d, 8.42 / d, 7.61 / m, 7.38 / m, 7.27 / m, 5.00 / s, 1.72 / s) / d)

LC/MS: m/z=675[(M+1)+]
LC / MS: m / z = 675 [(M + 1) < + &

합성예 10 : [화합물 122]의 합성Synthesis Example 10: Synthesis of [Compound 122]

Figure pat00087
Figure pat00087

[중간체 18-1](5.0 g, 0.010 mol)에 5-bromo-7,7-dimethyl-9-phenyl-7H-benzo[c]fluorene(3.2 g, 0.008 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 122] 3.9g (수율 72%)을 얻었다.7-dimethyl-9-phenyl-7H-benzo [c] fluorene (3.2 g, 0.008 mol) was added to a solution of Intermediate 18-1 (5.0 g, 0.010 mol) ) To obtain 3.9 g (yield: 72%) of [Compound 122].

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.56/d, 8.52/d, 8.15/d, 8.01/d, 7.99/s, 7.88/d, 7.83/s, 7.75/d, 7.69/d, 7.54/m, 7.41/m, 7.38/m, 7.36/m, 7.26/m, 7.17/d) 2H(7.52/d, 7.27/m, 5.00/s, 1.78/s) 3H(7.51/m) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.56 / d, 8.52 / d, 8.15 / d, 8.01 / d, 7.99 / s, 7.88 / d, 7.83 / s, 7.75 / d, 7.69 / d (7.52 / d, 7.27 / m, 5.00 / s, 1.78 / s) 3H (7.51 / m) (7.40 / m, 7.29 / d)

LC/MS: m/z=675[(M+1)+]
LC / MS: m / z = 675 [(M + 1) < + &

합성예 11 : [화합물 149]의 합성Synthesis Example 11: Synthesis of [Compound 149]

Figure pat00088
Figure pat00088

[중간체 1-3](5.0 g, 0.010 mol)에 3-bromopyridine(1.9 g, 0.012 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 149] 3.7g (수율 73%)을 얻었다.(1.9 g, 0.012 mol) was added to a solution of the intermediate [1-3] (5.0 g, 0.010 mol) in the same manner as in Synthesis Example 1- (4) %).

H-NMR (200MHz, CDCl3):δ ppm, 1H(9.24/s, 8.70/d, 8.42/d, 8.01/d, 7.88/d, 7.75/d, 7.57/m, 7.38/m, 7.36/m, 7.21/m, 7.17/d) 2H(7.27/m, 5.00/s) 4H(7.40/m, 7.29/d, 7.25/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (9.24 / s, 8.70 / d, 8.42 / d, 8.01 / d, 7.88 / d, 7.75 / d, 7.57 / m, 7.38 / m, 7.36 / m (7.27 / m, 5.00 / s) 4H (7.40 / m, 7.29 / d, 7.25 / d)

LC/MS: m/z=510[(M+1)+]
LC / MS: m / z = 510 [(M + 1) < + &

합성예 12 : [화합물 158]의 합성Synthesis Example 12: Synthesis of [Compound 158]

(1) [중간체 158-1]의 합성(1) Synthesis of [intermediate 158-1]

Figure pat00089
Figure pat00089

[중간체 1-2](5.0 g, 0.011 mol)에 4-tert-butylaniline(1.6 g, 0.011 mol) Pd(dba)2(0.5 g, 0.0006 mol), sodium-tert-butoxide(2.1 g, 0.022 mol)에 톨루엔 80 mL를 넣고 95 ℃에서 6시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 [중간체 158-1]을 3.8g(70%)수득하였다.(m/z=503)
Tert-butylaniline (1.6 g, 0.011 mol) Pd (dba) 2 (0.5 g, 0.0006 mol) and sodium-tert-butoxide (2.1 g, 0.022 mol) in DMF ), 80 mL of toluene was added, and the mixture was reacted at 95 DEG C for 6 hours with stirring. After completion of the reaction, the reaction mixture was cooled, and the product was separated into H 2 O: MC and column-purified (n-hexane: MC) to obtain 3.8 g (70%) of [intermediate 158-1]

(2) [화합물 158]의 합성(2) Synthesis of [Compound 158]

Figure pat00090
Figure pat00090

[중간체 158-1](5.0 g, 0.010 mol)에 4-bromobenzonitrile(1.8 g, 0.010 mol)를 넣고 합성예 1-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 158] 4.3g (수율 72%)을 얻었다.(m/z=604)4-bromobenzonitrile (1.8 g, 0.010 mol) was added to a solution of the intermediate 158-1 (5.0 g, 0.010 mol) in the same manner as in Synthesis Example 1- (1) %). (M / z = 604)

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.75/d, 7.36/m, 7.35/m, 7.26/m, 7.17/d, 2.87/s) 2H(7.39/d, 7.27/m, 7.05/d, 6.81/d, 6.55/d, 5.00/s, 1.20/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.75 / d, 7.36 / m, 7.35 / m, 7.26 / m, 7.17 / d, 2.87 / s) 2H (7.39 / d, 7.27 / m, 7.05 / d, 6.81 / d, 6.55 / d, 5.00 / s, 1.20 / s)

LC/MS: m/z=605[(M+1)+]
LC / MS: m / z = 605 [(M + 1) < + &

합성예 13 : [화합물 161]의 합성Synthesis Example 13: Synthesis of [Compound 161]

(1) [중간체 161-0]의 합성(1) Synthesis of [intermediate 161-0]

Figure pat00091
Figure pat00091

9-chloroanthracene(5.0 g, 0.024 mol)에 perbromoethene(8.2 g, 0.024 mol) 를 넣고 합성예 1-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 161-0] 7.1g (수율 75%)을 얻었다.(m/z=396)
7.1 g (yield 75%) of [intermediate 161-0] was synthesized by the same method as in Synthesis Example 1- (1), except that perbromoethene (8.2 g, 0.024 mol) was added to 9-chloroanthracene (M / z = 396).

(2) [중간체 161-1]의 합성(2) Synthesis of [intermediate 161-1]

Figure pat00092
Figure pat00092

[중간체 161-0](5.0 g, 0.013 mol)에 diphenylamine(2.1 g, 0.013 mol)를 넣고 합성예 1-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 161-1] 4.5g (수율 72%)을 얻었다.(m/z=484)
4.5 g (yield 72%) of [intermediate 161-1] was synthesized by the same method as in Synthesis Example 1- (1), except that diphenylamine (2.1 g, 0.013 mol) %). (M / z = 484)

(3) [중간체 161-2]의 합성(3) Synthesis of [intermediate 161-2]

Figure pat00093
Figure pat00093

[중간체 161-1](5.0 g, 0.010 mol)에 1,4-phenylenediboronic acid(2.2 g, 0.012 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체161-2] 3.6g (수율 75%)을 얻었다.(m/z=482)
Intermediate 161-2 was synthesized by the same method as in Synthesis Example 1- (4), except that 1,4-phenylenediboronic acid (2.2 g, 0.012 mol) was added to the intermediate 161-1 (5.0 g, 0.010 mol) 3.6 g (yield 75%) of the title compound (m / z = 482)

(4) [중간체 161-3]의 합성(4) Synthesis of [intermediate 161-3]

Figure pat00094
Figure pat00094

3,5-difluoroaniline(3.0 g, 0.023 mol)에 1-bromo-3,5-difluorobenzene(4.5 g, 0.023 mol)를 넣고 합성예 1-(1)에서 사용된 동일한 방법으로 합성하여 [중간체161-3] 3.8g (수율 70%)을 얻었다.(m/z=241)
Synthesis was conducted in the same manner as in Synthesis Example 1- (1) except that 1-bromo-3,5-difluorobenzene (4.5 g, 0.023 mol) was added to 3,5-difluoroaniline (3.0 g, 0.023 mol) 3] (yield: 70%). (M / z = 241)

(5) [화합물 161]의 합성(5) Synthesis of [Compound 161]

Figure pat00095
Figure pat00095

[중간체 161-2](5.0 g, 0.010 mol)에 [중간체 161-3](2.4 g, 0.010 mol)를 넣고 합성예 1-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 161] 4.6g (수율 67%)을 얻었다.(m/z=476)[Compound 161] was synthesized by the same method as in Synthesis Example 1- (1), except that [Intermediate 161-3] (2.4 g, 0.010 mol) was added to the intermediate 161-2 (5.0 g, 0.010 mol) (Yield: 67%). (M / z = 476)

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/s, 7.75/d, 7.36/m, 7.35/d, 7.27/m, 7.26/m, 7.17/d) 2H(7.40/m, 7.29/d, 6.77/m, 6.04/s, 4.85/s) 4H(7.33/d, 7.23/d, 6.34/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / s, 7.75 / d, 7.36 / m, 7.35 / d, 7.27 / m, 7.26 / m, 7.17 / d) 2H (7.40 (7.23 / d, 6.77 / m, 6.04 / s, 4.85 / s)

LC/MS: m/z=687[(M+1)+]
LC / MS: m / z = 687 [(M + 1) < + &

합성예 14 : [화합물 166]의 합성Synthesis Example 14: Synthesis of [Compound 166]

(1) [중간체 166-1]의 합성(1) Synthesis of [intermediate 166-1]

Figure pat00096
Figure pat00096

[중간체 166-0](5.0 g, 0.013 mol)에 phenyl-boronicacid(2.1 g, 0.013 mol) 를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 166-1] 3.6g (수율 70%)을 얻었다.(m/z=393)
Boronicacid (2.1 g, 0.013 mol) was added to the intermediate 166-0 (5.0 g, 0.013 mol), and 3.6 g (intermediate 166-1) of Intermediate 166-1 was synthesized in the same manner as in Synthesis Example 1- Yield: 70%). (M / z = 393)

(2) [중간체 166-2]의 합성(2) Synthesis of [Intermediate 166-2]

Figure pat00097
Figure pat00097

[중간체 166-1](5.0 g, 0.013 mol)에 bis(4-tert-butylphenyl)amine(3.7 g, 0.013 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체166-2] 5.5g (수율 71%)을 얻었다.(m/z=594)
Was synthesized in the same manner as in Synthesis Example 12- (1) except that bis (4-tert-butylphenyl) amine (3.7 g, 0.013 mol) was added to the intermediate 166-1 (5.0 g, 0.013 mol) -2] (yield: 71%). (M / z = 594)

(3) [화합물 166]의 합성(3) Synthesis of [Compound 166]

Figure pat00098
Figure pat00098

[중간체 166-2](5.0 g, 0.008 mol)에 bis(4-tert-butylphenyl)amine(2.3 g, 0.008 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 166] 4.7g (수율 71%)을 얻었다.Synthesis was carried out in the same manner as in Synthesis Example 12- (1) except that bis (4-tert-butylphenyl) amine (2.3 g, 0.008 mol) was added to the intermediate 166-2 (5.0 g, 0.008 mol) ] (Yield: 71%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.75/d, 7.36/m, 7.35/m, 7.27/m, 7.26/m, 7.17/d) 2H(7.40/m, 7.29/d, 4.85/s) 8H(7.01/d, 6.55/d) 12H(1.35/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.75 / d, 7.36 / m, 7.35 / m, 7.27 / m, 7.26 / m, 7.17 / d) 2H (7.40 / m, 7.29 / d, 4.85 / s) 8H (7.01 / d, 6.55 / d) 12H (1.35 / s)

LC/MS: m/z=840[(M+1)+]
LC / MS: m / z = 840 [(M + 1) < + &

합성예 15 : [화합물 168]의 합성Synthesis Example 15: Synthesis of [Compound 168]

(1) [중간체 168-1]의 합성(1) Synthesis of [intermediate 168-1]

Figure pat00099
Figure pat00099

2-fluorobiphenyl-4-amine(5.0 g, 0.027 mol)에 bromobenzene(4.2 g, 0.027 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 168-1] 5.8g (수율 82%)을 얻었다.(m/z=263)
Bromobenzene (4.2 g, 0.027 mol) was added to 2-fluorobiphenyl-4-amine (5.0 g, 0.027 mol) in the same manner as in Synthesis Example 12- (1) 82%). (M / z = 263)

(3) [중간체 168-2]의 합성(3) Synthesis of [intermediate 168-2]

Figure pat00100
Figure pat00100

[중간체 166-1](5.0 g, 0.013 mol)에 [중간체 15-1](3.4 g, 0.013 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 168-2] 5.3g (수율 71%)을 얻었다.(m/z=576)
[Intermediate 168-2] was synthesized by the same method as in Synthesis Example 12- (1), except that [Intermediate 15-1] (3.4 g, 0.013 mol) was added to the intermediate 166-1 (5.0 g, 0.013 mol) 5.3 g (yield: 71%) was obtained. (M / z = 576)

(4) [화합물 168]의 합성(4) Synthesis of [Compound 168]

Figure pat00101
Figure pat00101

[중간체 168-2](5.0 g, 0.009 mol)에 [중간체 168-1](2.3 g, 0.009 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 168] 5.6g (수율 77%)을 얻었다.[Compound 168-1] (2.3 g, 0.009 mol) was added to the intermediate 168 - [intermediate 168-2] (5.0 g, 0.009 mol) (Yield: 77%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.75/d, 7.55/d, 7.36/m, 7.35/m, 7.27/m, 7.26/m, 7.17/d, 6.81/m, 6.77/m, 6.60/d, 6.46/d, 6.43/d) 2H(7.41/m, 7.40/m, 7.33/d, 7.29/d, 7.23/m, 7.20/m, 4.85/d) 3H(6.63/d) 4H(7.51/m) 5H(7.52/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.75 / d, 7.55 / d, 7.36 / m, 7.35 / m, 7.27 / m, 7.26 / m, 7.17 / d M, 6.81 / m, 6.77 / m, 6.60 / d, 6.46 / d, 6.43 / d) 2H (7.41 / m, 7.40 / m, 7.33 / d, 7.29 / d, 7.23 / ) 3H (6.63 / d) 4H (7.51 / m) 5H (7.52 / d)

LC/MS: m/z=803[(M+1)+]
LC / MS: m / z = 803 [(M + 1) < + &

실시예 16 : [화합물 184]의 합성Example 16: Synthesis of [Compound 184]

(1) [중간체 184-1]의 합성(1) Synthesis of [intermediate 184-1]

Figure pat00102
Figure pat00102

[중간체 1-2](5.0 g, 0.011 mol)에 4-(trimethylsilyl)aniline(2.1 g, 0.011 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 184-1] 3.6g (수율 63%)을 얻었다.(m/z=519)
[Intermediate 184-1] was synthesized by the same method as in Synthesis Example 12- (1), except that 4- (trimethylsilyl) aniline (2.1 g, 0.011 mol) 3.6 g (yield: 63%) was obtained. (M / z = 519)

(2) [중간체 184-2]의 합성(2) Synthesis of [intermediate 184-2]

Figure pat00103
Figure pat00103

[중간체 184-1](5.0 g, 0.010 mol)에 1,2,5-tribromo-3-(trifluoromethyl)benzene(3.8 g, 0.010 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 184-2] 5.9g (수율 72%)을 얻었다.(m/z=821)
1,2,5-tribromo-3- (trifluoromethyl) benzene (3.8 g, 0.010 mol) was added to the intermediate 184-1 (5.0 g, 0.010 mol) (M / z = 821) as an intermediate [184-2] (yield: 72%).

(3) [화합물 184]의 합성(3) Synthesis of [Compound 184]

Figure pat00104
Figure pat00104

[중간체 184-2](5.0 g, 0.006 mol)에 1,4-phenylenediboronic acid(1.1 g, 0.007 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 184] 3.5g (수율 71%)을 얻었다.3.5 g (0.007 mol) of [compound 184-2] was synthesized in the same manner as in Synthesis Example 1- (4), except that 1,4-phenylenediboronic acid (1.1 g, 0.007 mol) (Yield: 71%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.89/s, 7.87/d, 7.75/m, 7.45/d, 7.36/m, 7.35/m, 7.26/m, 7.17/d) 2H(7.52/d, 7.41/m, 7.27/d, 7.15/d, 7.08/d, 6.61/d, 5.00/s) 3H(0.25/s) 4H(7.51/m, 7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.89 / s, 7.87 / d, 7.75 / m, 7.45 / d, 7.36 / m, 7.35 / m, 7.26 / m, 7.17 / d M), 7.29 / d (7.52 / d, 7.41 / m, 7.27 / d, 7.15 / d, 7.08 / d, 6.61 / d, 5.00 / )

LC/MS: m/z=817[(M+1)+]
LC / MS: m / z = 817 [(M + 1) < + &

합성예 17 : [화합물 186]의 합성Synthesis Example 17: Synthesis of [Compound 186]

(1) [중간체 186-1]의 합성(1) Synthesis of [intermediate 186-1]

Figure pat00105
Figure pat00105

[중간체 1-2](5.0 g, 0.011 mol)에 4-fluoroaniline(1.2 g, 0.011 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 186-1] 3.1g (수율 60%)을 얻었다.(m/z=465)
(1.2 g, 0.011 mol) was added to a mixture of the intermediate [1-2] (5.0 g, 0.011 mol) and 3.1 g (intermediate 186-1) of Intermediate 186-1 synthesized in the same manner as in Synthesis Example 12- Yield: 60%). (M / z = 465)

(2) [중간체 186-2]의 합성(2) Synthesis of [intermediate 186-2]

Figure pat00106
Figure pat00106

[중간체 1-2](5.0 g, 0.011 mol)에 1-bromo-2,4-dichlorobenzene(2.5 g, 0.011 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 186-2] 4.8g (수율 72%)을 얻었다.(m/z=610)
Was synthesized in the same manner as in Synthesis Example 12- (1) except that 1-bromo-2,4-dichlorobenzene (2.5 g, 0.011 mol) was added to [Intermediate 1-2] (5.0 g, 0.011 mol) -2] (yield: 72%). (M / z = 610)

(3) [화합물 186]의 합성(3) Synthesis of [Compound 186]

Figure pat00107
Figure pat00107

[중간체 186-2](5.0 g, 0.008 mol)에 1,4-phenylenediboronic acid(3.4 g, 0.020 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 <화합물186> 4.0g (수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Synthesis Example 1- (4), except that 1,4-phenylenediboronic acid (3.4 g, 0.020 mol) was added to the intermediate 186-2 (5.0 g, 0.008 mol) (Yield: 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.75/d, 7.50/d, 7.45/s, 7.36/m, 7.35/m, 7.26/m, 7.17/d, 6.75/d) 2H(7.52/d, 7.41/m, 7.27/m, 7.08/d, 6.99/d, 6.61/d, 5.00/s) 4H(7.51/m, 7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.75 / d, 7.50 / d, 7.45 / s, 7.36 / m, 7.35 / m, 7.26 / m, 7.17 / d (7.51 / m, 7.40 / m, 7.29 / d), 6.75 / d) 2H (7.52 / d, 7.41 / m, 7.27 / m, 7.08 / d, 6.99 / d, 6.61 /

LC/MS: m/z=694[(M+1)+]
LC / MS: m / z = 694 [(M + 1) &lt; + &

합성예 18 : [화합물 194]의 합성Synthesis Example 18: Synthesis of [Compound 194]

(1) [중간체 194-1]의 합성(1) Synthesis of [intermediate 194-1]

Figure pat00108
Figure pat00108

2-bromobenzenethiol(5.0 g, 0.026 mol)에 1-(2-chlorophenyl)ethanone(4.0 g, 0.026 mol)를 넣고 합성예 1-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 194-1] 5.6g (수율 70%)을 얻었다.(m/z=307)
[Intermediate 194-1] was synthesized by the same method as in Synthesis Example 1- (1), except that 1- (2-chlorophenyl) ethanone (4.0 g, 0.026 mol) was added to 2-bromobenzenethiol (5.0 g, 0.026 mol) g (yield: 70%). (m / z = 307)

(2) [중간체 194-2]의 합성(2) Synthesis of [intermediate 194-2]

Figure pat00109
Figure pat00109

[중간체 194-1](5.0 g, 0.016 mol)에 magnesium bromide(3.5 g, 0.019 mol)를 넣고 합성예 1-(2)에서 사용된 동일한 방법으로 합성하여 [중간체 194-2] 4.6g (수율89%)을 얻었다.(m/z=323)
(3.5 g, 0.019 mol) was added to the intermediate 194-1 (5.0 g, 0.016 mol) in the same manner as in Synthesis Example 1- (2) to obtain 4.6 g of Intermediate 194-2 89%). (M / z = 323)

(3) [중간체 194-3]의 합성(3) Synthesis of [intermediate 194-3]

Figure pat00110
Figure pat00110

[중간체 194-2](5.0 g, 0.015 mol)를 합성예 1-(3)에서 사용된 동일한 방법으로 합성하여 [중간체 194-3] 4.3g (수율93%)을 얻었다.(m/z=305)
[Synthesis of intermediate 194-2] (5.0 g, 0.015 mol) was synthesized in the same manner as in Synthesis Example 1- (3) to give 4.3 g (yield 93%) of [intermediate 194-3] 305)

(4) [중간체 194-4]의 합성(4) Synthesis of [intermediate 194-4]

Figure pat00111
Figure pat00111

[중간체 1-2](5.0 g, 0.011 mol)에 2,4-dibromo-6-fluoroaniline(2.9 g, 0.011 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 194-4] 4.9g (수율 72%)을 얻었다.(m/z=623)
Was synthesized in the same manner as in Synthesis Example 12- (1) except that 2,4-dibromo-6-fluoroaniline (2.9 g, 0.011 mol) was added to [Intermediate 1-2] (5.0 g, 0.011 mol) -4] (yield: 72%). (M / z = 623)

(5) [중간체 194-5]의 합성(5) Synthesis of [intermediate 194-5]

Figure pat00112
Figure pat00112

[중간체 194-4](5.0 g, 0.008 mol)에 phenylboronic acid(3.4 g, 0.020 mol) 를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 194-5] 3.1g (수율 63%)을 얻었다.(m/z=617)
(3.4 g, 0.020 mol) was added to the intermediate 194-4 (5.0 g, 0.008 mol) in the same manner as in Synthesis Example 1- (4) 63%). (M / z = 617)

(6) [화합물 194]의 합성(6) Synthesis of [Compound 194]

Figure pat00113
Figure pat00113

[중간체 194-5](5.0 g, 0.008 mol)에 4-bromo-9,9-dimethyl-9H-thioxanthene (2.4 g, 0.008 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 194] 4.0g (수율 60%)을 얻었다.Synthesis was carried out in the same manner as in Synthesis Example 12- (1) except that 4-bromo-9,9-dimethyl-9H-thioxanthene (2.4 g, 0.008 mol) was added to the intermediate 194-5 (5.0 g, 0.008 mol) To obtain 4.0 g (yield: 60%) of [Compound 194].

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.75/d, 7.69/d, 7.36/m, 7.35/m, 7.34/m, 7.26/m, 7.23/s, 7.22/s, 7.17/d, 7.11/m, 7.10/d, 6.86/m, 6.46/d, 6.25/d) 2H(7.52/d, 7.41/m, 7.27/m, 7.08/d, 5.00/s, 1.72/s) 4H(7.51/m, 7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.75 / d, 7.69 / d, 7.36 / m, 7.35 / m, 7.34 / m, 7.26 / m, 7.23 / s M, 7.27 / d, 7.11 / m, 7.10 / d, 6.86 / m, 6.46 / d, 6.25 / d) 2H (7.52 / d, 7.41 / , 1.72 / s) 4H (7.51 / m, 7.40 / m, 7.29 / d)

LC/MS: m/z=843[(M+1)+]
LC / MS: m / z = 843 [(M + 1) &lt; + &

합성예 19 : [화합물 216]의 합성Synthesis Example 19: Synthesis of [Compound 216]

Figure pat00114
Figure pat00114

[중간체 184-1](5.0 g, 0.010 mol)에 4-bromobenzonitrile(1.8 g, 0.010 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 216] 4.5g (수율 72%)을 얻었다.(m/z=821)4.5 g (yield: 72%) was obtained by synthesizing 4-bromobenzonitrile (1.8 g, 0.010 mol) in the intermediate 184-1 (5.0 g, 0.010 mol) %). (M / z = 821)

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.75/d, 7.36/m, 7.35/m, 7.26/m, 7.17/d) 2H(7.39/d, 7.27/m, 7.15/d, 6.81/d, 6.61/d, 5.00/s) 3H(0.25/s) 4H(7.40/m, 7.29/d ) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.75 / d, 7.36 / m, 7.35 / m, 7.26 / m, 7.17 / d) 2H (7.39 / d, 7.27 m), 7.15 / d, 6.81 / d, 6.61 / d, 5.00 /

LC/MS: m/z=621[(M+1)+]
LC / MS: m / z = 621 [(M + 1) &lt; + &

합성예 20 : [화합물 237]의 합성Synthesis Example 20: Synthesis of [Compound 237]

(1) [중간체 237-1]의 합성(1) Synthesis of [Intermediate 237-1]

Figure pat00115
Figure pat00115

[중간체 1-2](5.0 g, 0.011 mol)에 9,9-dimethyl-9H-fluoren-2-amine(2.3 g, 0.011mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 <중간체237-1> 4.3g (수율 70%)을 얻었다.(m/z=563)
9,9-dimethyl-9H-fluoren-2-amine (2.3 g, 0.011 mol) was added to the intermediate 1-2 (5.0 g, 0.011 mol) (M / z = 563) of <Intermediate 237-1> (yield: 70%).

(2) [화합물 237]의 합성(2) Synthesis of [Compound 237]

Figure pat00116
Figure pat00116

[중간체 237-1](5.0 g, 0.009 mol)에 5-bromoisophthalonitrile(2.3 g, 0.009 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 237] 4.7g (수율 75%)을 얻었다.(m/z=476)(Compound 237) (4.7 g, yield 75%) was synthesized by the same method as in Synthesis Example 12- (1), except that 5-bromoisophthalonitrile (2.3 g, 0.009 mol) %). (M / z = 476)

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.75/d, 7.62/d, 7.55/d, 7.38/m, 7.36/m, 7.35/m, 7.28/m, 7.26/m, 7.17/d, 6.87/s, 6.75/s, 6.58/d) 2H(7.87/d, 7.27/m, 7.00/s, 5.00/s, 1.72/s) 4H(7.40/m ,7.29/d ) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.75 / d, 7.62 / d, 7.55 / d, 7.38 / m, 7.36 / m, 7.35 / m, 7.28 / m, 7.26 / m (7.17 / d, 6.87 / s, 6.75 / s, 6.58 / d) 2H (7.87 / d, 7.27 / m, 7.00 / s, 5.00 / s, 1.72 / s)

LC/MS: m/z=690[(M+1)+]
LC / MS: m / z = 690 [(M + 1) &lt; + &

합성예 21 : [화합물 248]의 합성Synthesis Example 21: Synthesis of [Compound 248]

(1) [중간체 248-1]의 합성(1) Synthesis of [intermediate 248-1]

Figure pat00117
Figure pat00117

[중간체 184-2](5.0 g, 0.006 mol)에 phenylboronicacid(1.1 g, 0.007 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 248-1] 3.2g (수율 66%)을 얻었다.(m/z=818)
3.2 g (yield: 66%) of [intermediate 248-1] was synthesized in the same manner as in Synthesis Example 1- (4), except that phenylboronicacid (1.1 g, 0.007 mol) %). (M / z = 818)

(2) [화합물 248]의 합성(2) Synthesis of [Compound 248]

Figure pat00118
Figure pat00118

[중간체 248-1](5.0 g, 0.006 mol)에 naphthalen-1-ylboronic acid(21.2 g, 0.007mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 248] 3.0g (수율 61%)을 얻었다.(248-1) (5.0 g, 0.006 mol) was added naphthalen-1-ylboronic acid (21.2 g, 0.007 mol) (Yield: 61%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/m, 7.95/d, 7.87/d, 7.75/m, 7.61/m, 7.41/d, 7.36/m, 7.35/m, 7.26/m, 7.23/s, 7.22/s, 7.17/d) 2H(7.55/m, 7.51/m, 7.27/m, 7.15/d, 7.08/d, 6.61/d, 5.00/s) 3H(0.25/s) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / m, 7.95 / d, 7.87 / d, 7.75 / m, 7.61 / m, 7.41 / d M, 7.35 / m, 7.26 / m, 7.23 / s, 7.22 / s, 7.17 / d) 2H (7.55 / m, 7.51 / m, 7.27 / m, 7.15 / d, 7.08 / d, 6.61 / , 5.00 / s) 3H (0.25 / s) 4H (7.40 / m, 7.29 / d)

LC/MS: m/z=817[(M+1)+]
LC / MS: m / z = 817 [(M + 1) &lt; + &

합성예 22 : [화합물 249]의 합성Synthesis Example 22: Synthesis of [Compound 249]

(1) [중간체 249-1]의 합성(1) Synthesis of [Intermediate 249-1]

Figure pat00119
Figure pat00119

[중간체 1-2](5.0 g, 0.011 mol)에 4-aminobenzonitrile(1.3 g, 0.011 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 249-1] 3.7g (수율 72%)을 얻었다.(m/z=472)
(Intermediate 249-1) was synthesized in the same manner as in Synthesis Example 12- (1), except that 4-aminobenzonitrile (1.3 g, 0.011 mol) was added to the intermediate 1-2 (5.0 g, 0.011 mol) Yield: 72%). (M / z = 472)

(2) [중간체 249-2]의 합성(2) Synthesis of [intermediate 249-2]

Figure pat00120
Figure pat00120

[중간체 249-1](5.0 g, 0.010 mol)에 1,2,5-tribromo-3-fluorobenzene(3.3 g, 0.010 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 249-2] 5.4g (수율 74%)을 얻었다.(m/z=724)
1,2,5-tribromo-3-fluorobenzene (3.3 g, 0.010 mol) was added to the intermediate 249-1 (5.0 g, 0.010 mol) 5.4 g (yield: 74%) of intermediate 249-2 (m / z = 724)

(3) [중간체 249-3]의 합성(3) Synthesis of [intermediate 249-3]

Figure pat00121
Figure pat00121

[중간체 249-2](5.0 g, 0.007 mol)에 phenylboronicacid(1.4 g, 0.008 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 249-3] 3.5g (수율 70%)을 얻었다.(m/z=721)
3.5 g (yield: 70%) of [intermediate 249-3] was synthesized in the same manner as in Synthesis Example 1- (4), except that phenylboronic acid (1.4 g, 0.008 mol) %). (M / z = 721)

(4) [화합물 249]의 합성(4) Synthesis of [Compound 249]

Figure pat00122
Figure pat00122

[중간체 249-3](5.0 g, 0.007 mol)에 naphthalen-1-ylboronic acid(2.2 g, 0.008 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 249] 3.9g (수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Synthesis Example 1- (4), except that naphthalen-1-ylboronic acid (2.2 g, 0.008 mol) was added to the intermediate 249-3 (5.0 g, 0.007 mol) (Yield: 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 7.95/d, 7.87/d, 7.75/d, 7.61/m, 7.41/d, 7.36/m, 7.35/m, 7.26/m, 7.17/d) 2H(7.55/m, 7.51/m, 7.39/d, 7.27/m, 7.08/d, 6.81/d, 5.00/s) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / d, 7.95 / d, 7.87 / d, 7.75 / d, 7.61 / m, 7.41 / d 7.36 / m, 7.35 / m, 7.26 / m, 7.17 / d) 2H (7.55 / m, 7.51 / m, 7.39 / d, 7.27 / m, 7.08 / d, 6.81 / d, 5.00 / / m, 7.29 / d)

LC/MS: m/z=769[(M+1)+]
LC / MS: m / z = 769 [(M + 1) &lt; + &

합성예 23 : [화합물 266]의 합성Synthesis Example 23: Synthesis of [Compound 266]

(1) [중간체 266-1]의 합성(1) Synthesis of [intermediate 266-1]

Figure pat00123
Figure pat00123

[중간체 158-1](5.0 g, 0.010 mol)에 2,5-dibromobenzonitrile(2.6 g, 0.010 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 266-1] 4.8g (수율 72%)을 얻었다.(m/z=683)
[Intermediate 266-1] was synthesized by the same method as in Synthesis Example 12- (1), except that 2,5-dibromobenzonitrile (2.6 g, 0.010 mol) was added to [Intermediate 158-1] (5.0 g, 0.010 mol) g (yield 72%). (m / z = 683)

(2) [화합물 266]의 합성(2) Synthesis of [Compound 266]

Figure pat00124
Figure pat00124

[중간체 266-1](5.0 g, 0.007 mol)에 naphthalen-1-ylboronic acid(2.2 g, 0.008 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 266] 3.6g (수율 70%)을 얻었다.Compound 266] was synthesized by the same method as in Synthesis Example 1- (4), except that naphthalen-1-ylboronic acid (2.2 g, 0.008 mol) was added to the intermediate 266-1 (5.0 g, 0.007 mol) (Yield: 70%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 7.95/d, 7.87/d, 7.75/d, 7.72/d, 7.61/m, 7.36/m, 7.35/m, 7.26/m, 7.17/d, 6.97/d, 6.78/s) 2H(7.55/m, 7.27/m, 7.01/d, 6.55/d, 5.00/s) 3H(1.35/s) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / d, 7.95 / d, 7.87 / d, 7.75 / d, 7.72 / d, 7.61 / m 7.25 / d, 5.00 / s) 3H (1.35 &lt; RTI ID = 0.0 &gt; / s) 4H (7.40 / m, 7.29 / d)

LC/MS: m/z=731[(M+1)+]
LC / MS: m / z = 731 [(M + 1) &lt; + &

합성예 24 : [화합물 277]의 합성Synthesis Example 24: Synthesis of [Compound 277]

(1) [중간체 277-1]의 합성(1) Synthesis of [Intermediate 277-1]

Figure pat00125
Figure pat00125

[중간체 1-0](5.0 g, 0.016 mol)에 (9,9-dimethyl-9H-fluoren-2-yl)magnesium bromide(11.0 g, 0.037 mol)를 넣고 합성예 1-(2)에서 사용된 동일한 방법으로 합성하여 [중간체 277-1] 9.5g (수율85%)을 얻었다.(m/z=700)
(9.0-dimethyl-9H-fluoren-2-yl) magnesium bromide (11.0 g, 0.037 mol) was added to a solution of the intermediate 1-0 (5.0 g, 0.016 mol) Synthesis was conducted in the same manner to obtain 9.5 g (yield: 85%) of [intermediate 277-1] (m / z = 700)

(2) [중간체 277-2]의 합성(2) Synthesis of [intermediate 277-2]

Figure pat00126
Figure pat00126

[중간체 277-1](5.0 g, 0.007 mol)를 합성예 1-(3)에서 사용된 동일한 방법으로 합성하여 [중간체 277-2] 4.2g (수율90%)을 얻었다.(m/z=667)
[Synthesis of Intermediate 277-1] (5.0 g, 0.007 mol) was synthesized in the same manner as in Synthesis Example 1- (3) to give 4.2 g (yield 90% 667)

(3) [중간체 277-3]의 합성(3) Synthesis of [Intermediate 277-3]

Figure pat00127
Figure pat00127

[중간체 277-2](5.0 g, 0.008 mol)에 aniline(0.8 g, 0.008 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 277-3] 3.9g (수율 72%)을 얻었다.(m/z=684)
3.9 g of Intermediate 277-3 (yield 72%) was synthesized according to the same method as that of Synthesis Example 12- (1), except that aniline (0.8 g, 0.008 mol) was added to Intermediate 277-2 (5.0 g, 0.008 mol) %). (M / z = 684)

(4) [중간체 277-4]의 합성(4) Synthesis of [intermediate 277-4]

Figure pat00128
Figure pat00128

[중간체 277-2](5.0 g, 0.007 mol)에 1,2,5-tribromo-3-fluorobenzene(2.2 g, 0.007 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 277-4] 4.2g (수율 64%)을 얻었다.(m/z=936)
1,2,5-tribromo-3-fluorobenzene (2.2 g, 0.007 mol) was added to the intermediate 277-2 (5.0 g, 0.007 mol) (M / z = 936) of intermediate 277-4 (yield: 64%).

(5) [화합물 277]의 합성(5) Synthesis of [Compound 277]

Figure pat00129
Figure pat00129

[중간체 277-4](5.0 g, 0.005 mol)에 m-tolylboronic acid(0.9 g, 0.006 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 277] 3.6g (수율 74%)을 얻었다.Compound 277] was obtained in a yield of 3.6 g (yield: 97%) in the same manner as in Synthesis Example 1- (4), except that m-tolylboronic acid (0.9 g, 0.006 mol) 74%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.82/d, 7.79/s, 7.75/d, 7.69/d, 7.41/s, 7.36/m, 7.35/m, 7.33/m, 7.26/m, 7.24/d, 7.23/s, 7.22/s, 7.19/d, 7.17/d, 2.34/s) 2H(7.87/d, 7.55/d, 7.39/m, 7.38/m, 7.33/d, 7.28/m, 7.19/d, 5.00/s) 4H(1.72/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.82 / d, 7.79 / s, 7.75 / d, 7.69 / d, 7.41 / s, 7.36 / m, 7.35 / m 7.7 / d, 7.55 / d, 7.39 / m, 7.38 / m, 7.27 / d, 7.23 / , 7.33 / d, 7.28 / m, 7.19 / d, 5.00 / s) 4H (1.72 / s)

LC/MS: m/z=960[(M+1)+]
LC / MS: m / z = 960 [(M + 1) &lt; + &

합성예 25 : [화합물 288]의 합성Synthesis Example 25: Synthesis of [Compound 288]

(1) [중간체 288-1]의 합성(1) Synthesis of [intermediate 288-1]

Figure pat00130
Figure pat00130

[중간체 1-2](5.0 g, 0.011 mol)에 3,5-dibromophenylboronic acid(3.6 g, 0.013 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 288-1] 4.7g (수율 72%)을 얻었다.(m/z=590)
[Intermediate 288-1] was synthesized by the same method as in Synthesis Example 1- (4), except that 3,5-dibromophenylboronic acid (3.6 g, 0.013 mol) was added to [Intermediate 1-2] (5.0 g, 0.011 mol) (M / z = 590) of 4.7 g (yield 72%).

(2) [중간체 288-2]의 합성(2) Synthesis of [intermediate 288-2]

Figure pat00131
Figure pat00131

1,2,5-tribromo-3-fluorobenzene(5.0 g, 0.015 mol)에 phenylboronic acid (2.1 g, 0.017 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 288-2] 2.4g (수율 73%)을 얻었다.(m/z=327)
Synthesis was conducted in the same manner as in Synthesis Example 1- (4), except that phenylboronic acid (2.1 g, 0.017 mol) was added to 1,2,5-tribromo-3-fluorobenzene (5.0 g, 0.015 mol) ] (M / z = 327) (yield: 73%).

(3) [중간체 288-3]의 합성(3) Synthesis of [intermediate 288-3]

Figure pat00132
Figure pat00132

[중간체 25-2](5.0 g, 0.015 mol)에 4-aminobenzonitrile(1.8 g, 0.015 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 288-3] 4.1g (수율 75%)을 얻었다.(m/z=364)
4.1 g (intermediate 288-3) of 4-aminobenzonitrile (1.8 g, 0.015 mol) was added to the intermediate 25-2 (5.0 g, 0.015 mol) Yield: 75%). (M / z = 364)

(4) [화합물 288]의 합성(4) Synthesis of [Compound 288]

Figure pat00133
Figure pat00133

[중간체 288-2](5.0 g, 0.008 mol)에 [중간체 288-3](3.1 g, 0.016 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 288] 6.5g (수율 70%)을 얻었다.(m/z=476)[Compound 288] was synthesized in the same manner as in Synthesis Example 12- (1), except that [Intermediate 288-3] (3.1 g, 0.016 mol) was added to the intermediate 288-2 (5.0 g, 0.008 mol) (Yield: 70%). (M / z = 476)

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.01/d, 7.38/m, 7.36/d, 7.26/m, 7.17/d, 5.73/s) 2H(7.39/d, 7.27/m, 7.23/d, 7.22/d, 7.20/d, 7.08/d, 6.81/d, 6.63/d, 6.25/s, 5.00/s) 4H(7.41/m, 7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.01 / d, 7.38 / m, 7.36 / d, 7.26 / m, 7.17 / d, 5.73 / s) 2H (7.39 / d, 7.27 / m, 7.23 m, 7.40 / m, 7.29 / d). [0050]

LC/MS: m/z=1158[(M+1)+]
LC / MS: m / z = 1158 [(M + 1) &lt; + &

합성예 26 : [화합물 316]의 합성Synthesis Example 26: Synthesis of [Compound 316]

(1) [중간체 316-1]의 합성(1) Synthesis of [intermediate 316-1]

Figure pat00134
Figure pat00134

[중간체 1-2](5.0 g, 0.011 mol)에 4-bromophenylboronic acid(2.6 g, 0.013 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 316-1] 4.2g (수율 75%)을 얻었다.(m/z=511)
4.2 g (0.013 mol) of 4-bromophenylboronic acid was added to a solution of the intermediate [1-2] (5.0 g, 0.011 mol) and the intermediate 316-1 was synthesized in the same manner as in Synthesis Example 1- (4) (Yield: 75%). (M / z = 511)

(2) [중간체 316-2]의 합성(2) Synthesis of [Intermediate 316-2]

Figure pat00135
Figure pat00135

[중간체 316-1](5.0 g, 0.010 mol)에 4-isopropylaniline(1.4 g, 0.010 mol) 를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 316-2] 4.2g (수율 75%)을 얻었다.(m/z=565)
4.2 g of Intermediate 316-2 was synthesized in the same manner as in Synthesis Example 12- (1) except that 4-isopropylaniline (1.4 g, 0.010 mol) was added to the intermediate 316-1 (5.0 g, 0.010 mol) Yield: 75%). (M / z = 565)

(3) [화합물 316]의 합성(3) Synthesis of [Compound 316]

Figure pat00136
Figure pat00136

[중간체 316-2](5.0 g, 0.009 mol)에 3-bromodibenzo[b,d]thiophene(2.3 g, 0.009 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [화합물 316] 4.8g (수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Synthesis Example 12- (1) except that 3-bromodibenzo [b, d] thiophene (2.3 g, 0.009 mol) was added to the intermediate 316-2 (5.0 g, 0.009 mol) ] (Yield 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.45/d, 8.01/d, 7.98/d, 7.88/d, 7.80/d, 7.75/d, 7.52/m, 7.50/m, 7.38/m, 7.36/m, 7.26/m, 7.17/d, 7.06/s, 6.88/d, 2.87/s) 2H(7.54/d, 7.27/m, 7.05/d, 6.69/d, 6.55/d, 5.00/s, 1.20/s) 4H(7.40/m, 7.29/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.45 / d, 8.01 / d, 7.98 / d, 7.88 / d, 7.80 / d, 7.75 / d, 7.52 / m, 7.50 / m, 7.38 / m D, 7.26 / m, 7.05 / d, 7.06 / s, 6.88 / d, 2.87 / , 1.20 / s) 4H (7.40 / m, 7.29 / d)

LC/MS: m/z=748[(M+1)+]
LC / MS: m / z = 748 [(M + 1) &lt; + &

합성예 27 : [화합물 333]의 합성Synthesis Example 27: Synthesis of [Compound 333]

(1) [중간체 333-1]의 합성(1) Synthesis of [intermediate 333-1]

Figure pat00137
Figure pat00137

4-tert-butyl-N-phenylaniline(5.0 g, 0.022 mol)에 naphthalen-1-ylboronic acid(4.5 g, 0.026 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 333-1] 4.7g (수율 70%)을 얻었다.(m/z=308)
(4-tert-butyl-N-phenylaniline (5.0 g, 0.022 mol) was added naphthalen-1-ylboronic acid (4.5 g, 0.026 mol) -1] (m / z = 308) (yield: 70%).

(2) [중간체 333-2]의 합성(2) Synthesis of [intermediate 333-2]

Figure pat00138
Figure pat00138

[중간체 333-1](3.7 g, 0.012 mol)에 4-tert-butylaniline(1.8 g, 0.012 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 333-2] 3.3g (수율 73%)을 얻었다.(m/z=376)
[Intermediate 333-2] 3.3 g of 4-tert-butylaniline (1.8 g, 0.012 mol) was added to the intermediate 333-1 (3.7 g, 0.012 mol) g (yield: 73%). (m / z = 376)

(3) [중간체 333-3]의 합성(3) Synthesis of [intermediate 333-3]

Figure pat00139
Figure pat00139

[중간체 333-2](5.0 g, 0.013 mol)에 3-bromophenylboronic acid(2.6 g, 0.013 mol)를 넣고 합성예 12-(1)에서 사용된 동일한 방법으로 합성하여 [중간체 333-3] 4.7g (수율 73%)을 얻었다.(m/z=496)
The intermediate [333-3] was synthesized by the same method as in Synthesis Example 12- (1), except that 3-bromophenylboronic acid (2.6 g, 0.013 mol) was added to the intermediate 333-2 (5.0 g, 0.013 mol) (Yield: 73%). (M / z = 496)

(4) [중간체 333-4]의 합성(4) Synthesis of [intermediate 333-4]

Figure pat00140
Figure pat00140

[중간체 166-1](5.0 g, 0.013 mol)에 [중간체 333-3](7.4 g, 0.015 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [중간체 333-4] 7.1g (수율 72%)을 얻었다.(m/z=765)
[Intermediate 333-4] (7.4 g, 0.015 mol) was added to the intermediate [166-1] (5.0 g, 0.013 mol) 7.1 g (yield 72%) was obtained. (M / z = 765)

(5) [화합물 333]의 합성(5) Synthesis of [Compound 333]

Figure pat00141
Figure pat00141

[중간체 333-4](5.0 g, 0.007 mol)에 [중간체 333-3](4.0 g, 0.008 mol)를 넣고 합성예 1-(4)에서 사용된 동일한 방법으로 합성하여 [화합물 333] 5.6g (수율 72%)을 얻었다.[Compound 333] (4.0 g, 0.008 mol) was added to a solution of the intermediate 333-4 (5.0 g, 0.007 mol) in the same manner as in Synthesis Example 1- (4) (Yield: 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.95/d, 7.87/d, 7.75/s, 7.36/m, 7.35/m, 7.27/m, 7.26/m, 7.17/d) 2H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 7.72/d, 7.61/m, 7.40/m, 7.29/d, 7.04/d, 6.97/d, 6.78/s, 6.58/d, 5.00/s) 4H(7.55/m, 7.01/d, 6.55/d) 6H(1.35/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.95 / d, 7.87 / d, 7.75 / s, 7.36 / m, 7.35 / m, 7.27 / m, 7.26 / m, 7.17 / d) 2H (8.55 d, 8.42 / d, 8.08 / d, 8.04 / d, 7.72 d, 7.61 m, 7.40 m, 7.29 d, 7.04 d, 6.97 d, 6.78 s, 6.58 d, ) 4H (7.55 / m, 7.01 / d, 6.55 / d) 6H (1.35 / s)

LC/MS: m/z=1106[(M+1)+]
LC / MS: m / z = 1106 [(M + 1) &lt; + &

소자 실시예 1Device Embodiment 1

본 발명에 따른 유기 발광 [화합물 1]을 발광층의 형광 블루 호스트 재료로 하여 유기전계발광소자를 제조하였다.An organic electroluminescent device was fabricated using the organic luminescence [Compound 1] according to the present invention as a fluorescent blue host material in the luminescent layer.

ITO로 코팅된 유리기판 위에 CuPc를 80 nm, α-NPD를 30 nm를 성막한 후 [화합물 1] + [화합물 B] 6%를 혼?하여 25 nm, 증착속도 0.1 m/sec로 성막한 다음 Alq3를 40 nm, LiF을 1 nm, Al을 120 nm의 순서로 성막하여 유기전계발광소자를 제조하였다. 이때, 각 물질의 증착속도는 CuPc, α-NPD, Alq3는 0.1 nm/sec, LiF는 0.01 nm/sec, Al은 0.5 nm/sec로 하였다.
CuPc was deposited to 80 nm and α-NPD was deposited to 30 nm on a glass substrate coated with ITO, and 25% of [Compound 1] + [Compound B] 6% was mixed and the deposition rate was 0.1 m / sec. Alq 3 was formed in a thickness of 40 nm, LiF was formed in a thickness of 1 nm, and Al was formed in a thickness of 120 nm. Thus, an organic electroluminescent device was fabricated. At this time, deposition rates of CuPc, α-NPD, Alq 3 , LiF and Al were 0.5 nm / sec, 0.1 nm / sec, 0.01 nm / sec and 0.5 nm / sec, respectively.

소자 실시예 2 내지 15Device Embodiments 2 to 15

상기 [화합물 1] 대신 하기 [표 1]에 기재된 화합물을 사용한 것을 제외하고는 소자 실시예 1과 동일한 방법으로 소자 실시예 2 내지 15의 유기전계발광소자를 제조하였다.
Organic electroluminescent devices of Device Examples 2 to 15 were fabricated in the same manner as in Example 1 except that the compound described in [Table 1] was used in place of [Compound 1].

소자 비교예 1Device Comparative Example 1

비교예 1을 위한 유기발광다이오드 소자는 상기 실시예의 소자구조에서 본 발명에 의해 제조된 화합물 대신 일반적으로 형광 호스트 물질로 많이 사용되고 있는 [화합물 A](ADN)를 사용한 점을 제외하고 동일하게 제작하였다.
The organic light emitting diode device for the comparative example 1 was fabricated in the same manner except that the compound [A] (ADN), which is generally used as a fluorescent host material, was used in place of the compound prepared by the present invention in the device structure of the embodiment .

소자 실시예 16Device Embodiment 16

본 발명에 따른 유기 발광 [화합물 158]을 발광층의 형광 블루 도펀트 재료로 하여 유기전계발광소자를 제조하였다.An organic electroluminescent device was prepared using the organic luminescence [Compound 158] according to the present invention as a fluorescent blue dopant material of the light emitting layer.

ITO로 코팅된 유리기판 위에 CuPc를 80 nm, α-NPD를 30 nm를 성막한 후 [화합물 A] + [화합물 158] 6%를 혼?하여 25 nm, 증착속도 0.1 m/sec로 성막한 다음Alq3를 40 nm, LiF을 1 nm, Al을 120 nm의 순서로 성막하여 유기전계발광소자를 제조하였다. 이때, 각 물질의 증착속도는 CuPc, α-NPD, Alq3는 0.1 nm/sec, LiF는 0.01 nm/sec, Al은 0.5 nm/sec로 하였다.
CuPc was deposited to 80 nm and α-NPD was deposited to 30 nm on a glass substrate coated with ITO, and then 6% of [Compound A] + [Compound 158] was mixed to form a film with a deposition rate of 0.1 m / sec at 25 nm Alq 3 was formed in a thickness of 40 nm, LiF was formed in a thickness of 1 nm, and Al was formed in a thickness of 120 nm. Thus, an organic electroluminescent device was fabricated. At this time, deposition rates of CuPc, α-NPD, Alq 3 , LiF and Al were 0.5 nm / sec, 0.1 nm / sec, 0.01 nm / sec and 0.5 nm / sec, respectively.

소자 실시예 17 내지 35Device Examples 17 to 35

상기 [화합물 158] 대신 하기 [표 2]에 기재된 화합물을 사용한 것을 제외하고는 소자 실시예 16과 동일한 방법으로 소자 실시예 17 내지 35의 유기전계발광소자를 제조하였다.
Organic electroluminescent devices of Device Examples 17 to 35 were fabricated in the same manner as in Device Example 16, except that the compound described in [Table 2] was used instead of [Compound 158].

소자 비교예 2Device Comparative Example 2

비교예 2를 위한 유기발광다이오드 소자는 상기 실시예의 소자구조에서 본 발명에 의해 제조된 화합물 대신 일반적으로 형광 도펀트 물질로 많이 사용되고 있는 [화합물 B]를 사용한 점을 제외하고 동일하게 제작하였으며 상기 [화합물 A], [화합물 B]의 구조는 아래와 같다.The organic light emitting diode device for the comparative example 2 was fabricated in the same manner except that the compound [B], which is generally used as a fluorescent dopant material instead of the compound prepared by the present invention, was used in the device structure of the above- A] and [Compound B] have the following structures.

Figure pat00142
Figure pat00142

[화합물 A] [화합물 B][Compound A] [Compound B]

이하, 상기 소자 실시예 1 내지 35과 소 자비교예 1, 2에 따라 제조된 유기전계발광소자의 특성을 비교한 결과를 하기 [표 1] 및 [표 2]에 나타내었다.Hereinafter, the characteristics of the organic electroluminescent devices manufactured according to the device embodiments 1 to 35 and the microcavity fabrication examples 1 and 2 are compared, and the results are shown in [Table 1] and [Table 2] below.

[표 1][Table 1]

Figure pat00143
Figure pat00143

[표 2][Table 2]

Figure pat00144
Figure pat00144

[구동전압 및 발광효율 측정][Measurement of driving voltage and luminous efficiency]

유기발광소자(기판크기 : 25×25 ㎟ / 증착면적 : 2×2 ㎟)를 IVL 측정셋트(CS-2000+지그+IVL프로그램)에 고정한 후 전류를 1 mA/㎡씩 상승시키며 증착면의 발광 휘도(cd/㎡), 구동전압(V), 발광효율(cd/A)을 측정하여 상기 [표 1] 및 [표 2]에 나타내었다.After fixing the organic light emitting device (substrate size: 25 × 25 mm 2 / deposition area: 2 × 2 mm 2) to the IVL measurement set (CS-2000 + jig + IVL program), the current was increased by 1 mA / The luminance (cd / m 2), the driving voltage (V) and the luminous efficiency (cd / A) were measured and shown in Table 1 and Table 2, respectively.

상기 실시예 1 내지 35와 비교예 1, 2 및 [표 1], [표 2]의 결과로부터, 본 발명에 따른 화합물은 종래의 청색 형광발광재료(화합물 A, 화합물 B)를 사용한 경우보다 저전압 구동이 가능하고, 동시에 발광효율 특성이 매우 우수하므로, 표시소자, 디스플레이 소자 및 조명 등에 유용하게 사용될 수 있음을 알 수 있다.From the results of Examples 1 to 35 and Comparative Examples 1 and 2 and [Table 1] and [Table 2], it was found that the compound of the present invention exhibited lower voltage than that of the conventional blue fluorescent light emitting material (Compound A and Compound B) It can be used for a display device, a display device, an illumination, and the like.

Claims (13)

하기 [화학식 1] 내지 [화학식 2]로 표시되는 유기발광 화합물:
[화학식 1]
Figure pat00145

[화학식 2]
Figure pat00146

상기 [화학식 1] 내지 [화학식 2]에서,
L1 내지 L4는 서로 동일하거나 상이하고, 각각 독립적으로 단일결합이거나, 치환 또는 비치환된 아릴렌기, 치환 또는 비치환된 알케닐렌기, 치환 또는 비치환된 플루오레닐렌기, 치환 또는 비치환된 카바졸릴렌기 또는 N, O 및 S 원자 중 1개 이상을 포함하는 치환 또는 비치환된 헤테로아릴렌기이며,
Ar1은 치환 또는 비치환된 알킬기, 치환 또는 비치환된 시클로알킬기, 치환 또는 비치환된 알콕시기, 치환 또는 비치환된 아릴옥시기, 치환 또는 비치환된 알킬티옥시기, 치환 또는 비치환된 아릴티옥시기, 치환 또는 비치환된 알킬술폭시기, 치환 또는 비치환된 아릴술폭시기, 치환 또는 비치환된 알케닐기, 치환 또는 비치환된 실릴기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 알킬아민기, 치환 또는 비치환된 아랄킬아민기, 치환 또는 비치환된 아릴아민기, 치환 또는 비치환된 헤테로아릴아민기, 치환 또는 비치환된 아릴기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 카바졸기 또는 N, O 및 S 원자 중 1개 이상을 포함하는 치환 또는 비치환된 헤테로고리기이고,
R1 내지 R13은 서로 동일하거나 상이하고, 각각 독립적으로 수소, 중수소, 할로겐기, 니트릴기, 니트로기, 히드록시기, 치환 또는 비치환된 알킬기, 치환 또는 비치환된 시클로알킬기, 치환 또는 비치환된 알콕시기, 치환 또는 비치환된 아릴옥시기, 치환 또는 비치환된 알킬티옥시기, 치환 또는 비치환된 아릴티옥시기, 치환 또는 비치환된 알킬술폭시기, 치환 또는 비치환된 아릴술폭시기, 치환 또는 비치환된 알케닐기, 치환 또는 비치환된 실릴기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 알킬아민기, 치환 또는 비치환된 아랄킬아민기, 치환 또는 비치환된 아릴아민기, 치환 또는 비치환된 헤테로아릴아민기, 치환 또는 비치환된 아릴기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 카바졸기 또는 N, O, S 원자 중 1개 이상을 포함하는 치환 또는 비치환된 헤테로고리기이며,
n, b, c, d, e, f 및 g는 각각 독립적으로 0 또는 1이며, m 및 p는 0 내지 7의 정수이다.
An organic luminescent compound represented by the following Chemical Formulas 1 to 2:
[Chemical Formula 1]
Figure pat00145

(2)
Figure pat00146

In the above Chemical Formulas 1 to 2,
L 1 to L 4 are the same or different and are each independently a single bond, a substituted or unsubstituted arylene group, a substituted or unsubstituted alkenylene group, a substituted or unsubstituted fluorenylene group, a substituted or unsubstituted Or a substituted or unsubstituted heteroarylene group containing at least one of N, O and S atoms,
Ar 1 represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted alkylthio group, a substituted or unsubstituted aryl A substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted aryloxy group, An alkylamine group, a substituted or unsubstituted aralkylamine group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted heteroarylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted fluorenyl group, A substituted or unsubstituted carbazole group or a substituted or unsubstituted heterocyclic group containing at least one of N, O and S atoms,
R 1 to R 13 are the same or different from each other and are each independently selected from the group consisting of hydrogen, deuterium, halogen, nitrile, nitro, hydroxy, substituted or unsubstituted alkyl, A substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted alkylthio group, a substituted or unsubstituted arylthioxy group, a substituted or unsubstituted alkylsulfoxy group, a substituted or unsubstituted arylsulfoxy group, A substituted or unsubstituted alkyl group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted boron group, a substituted or unsubstituted alkylamine group, a substituted or unsubstituted aralkylamine group, A substituted or unsubstituted heteroaryl group, a substituted or unsubstituted heteroarylamine group, a substituted or unsubstituted aryl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted carbazole group or an atom of N, O, S A substituted or unsubstituted heterocyclic group,
n, b, c, d, e, f and g are each independently 0 or 1, and m and p are integers of 0 to 7.
제1항에 있어서,
상기 [화학식 1]은 하기 [화학식 1-1] 내지 [화학식 1-3] 중 어느 하나로 표시되는 것을 특징으로 하는 유기발광 화합물:
[화학식 1-1]
Figure pat00147

[화학식 1-2]
Figure pat00148

[화학식 1-3]
Figure pat00149

상기 [화학식 1-1] 내지 [화학식 1-3]에서, R1, R2 및 Ar1은 상기 [화학식 1]에서의 정의와 동일하다.
The method according to claim 1,
The organic luminescent compound represented by the formula (1) is represented by any one of the following formulas (1-1) to (1-3):
[Formula 1-1]
Figure pat00147

[Formula 1-2]
Figure pat00148

[Formula 1-3]
Figure pat00149

In the formulas (1-1) to (1-3), R 1 , R 2 and Ar 1 are the same as defined in the formula (1).
제1항에 있어서,
상기 [화학식 2]는 하기 [화학식 2-1] 내지 [화학식 2-5] 중 어느 하나로 표시되는 것을 특징으로 하는 유기발광 화합물:
[화학식 2-1]
Figure pat00150

[화학식 2-2]

[화학식 2-3]
Figure pat00152

[화학식 2-4]
Figure pat00153

[화학식 2-5]
Figure pat00154

상기 [화학식 2-1] 내지 [화학식 2-5]에서, R4 내지 R11은 상기 [화학식 2]에서의 정의와 동일하다.
The method according to claim 1,
(2) is represented by any one of the following formulas (2-1) to (2-5): &lt; EMI ID =
[Formula 2-1]
Figure pat00150

[Formula 2-2]

[Formula 2-3]
Figure pat00152

[Chemical Formula 2-4]
Figure pat00153

[Chemical Formula 2-5]
Figure pat00154

In the above formulas (2-1) to (2-5), R 4 to R 11 are the same as defined in the above formula (2).
제1항에 있어서,
상기 [화학식 1] 내지 [화학식 2]는 하기 화합물 1 내지 화합물 51로 이루어진 군으로부터 선택되는 어느 하나인 것을 특징으로 하는 유기발광 화합물:
Figure pat00155

Figure pat00156

Figure pat00157

Figure pat00158

Figure pat00159

Figure pat00160
The method according to claim 1,
(1) to (2) are any one selected from the group consisting of the following compounds 1 to 51:
Figure pat00155

Figure pat00156

Figure pat00157

Figure pat00158

Figure pat00159

Figure pat00160
제1항에 있어서,
상기 [화학식 1] 내지 [화학식 2]는 하기 화합물 52 내지 화합물 153으로 이루어진 군으로부터 선택되는 어느 하나인 것을 특징으로 하는 유기발광 화합물:
Figure pat00161

Figure pat00162

Figure pat00163

Figure pat00164

Figure pat00165

Figure pat00166

Figure pat00167

Figure pat00168

Figure pat00169

Figure pat00170

Figure pat00171

Figure pat00172
The method according to claim 1,
(1) to (2) are any one selected from the group consisting of the following compounds 52 to 153:
Figure pat00161

Figure pat00162

Figure pat00163

Figure pat00164

Figure pat00165

Figure pat00166

Figure pat00167

Figure pat00168

Figure pat00169

Figure pat00170

Figure pat00171

Figure pat00172
제1항에 있어서,
상기 [화학식 1] 내지 [화학식 2]는 하기 화합물 154 내지 화합물 183으로 이루어진 군으로부터 선택되는 어느 하나인 것을 특징으로 하는 유기발광 화합물:
Figure pat00173

Figure pat00174

Figure pat00175

Figure pat00176

Figure pat00177
The method according to claim 1,
(1) to (2) are any one selected from the group consisting of the following compounds 154 to 183:
Figure pat00173

Figure pat00174

Figure pat00175

Figure pat00176

Figure pat00177
제1항에 있어서,
상기 [화학식 1] 내지 [화학식 2]는 하기 화합물 184 내지 화합물 342로 이루어진 군으로부터 선택되는 어느 하나인 것을 특징으로 하는 화합물:
Figure pat00178

Figure pat00179

Figure pat00180

Figure pat00181

Figure pat00182

Figure pat00183

Figure pat00184

Figure pat00185

Figure pat00186

Figure pat00187

Figure pat00188

Figure pat00189

Figure pat00190

Figure pat00191

Figure pat00192

Figure pat00193

Figure pat00194

Figure pat00195

Figure pat00196

Figure pat00197

Figure pat00198

Figure pat00199

Figure pat00200

Figure pat00201
The method according to claim 1,
The compounds represented by the above formulas (1) to (2) are any one selected from the group consisting of the following compounds 184 to 342:
Figure pat00178

Figure pat00179

Figure pat00180

Figure pat00181

Figure pat00182

Figure pat00183

Figure pat00184

Figure pat00185

Figure pat00186

Figure pat00187

Figure pat00188

Figure pat00189

Figure pat00190

Figure pat00191

Figure pat00192

Figure pat00193

Figure pat00194

Figure pat00195

Figure pat00196

Figure pat00197

Figure pat00198

Figure pat00199

Figure pat00200

Figure pat00201
제1 전극, 제2 전극, 및 상기 제1 전극과 제2 전극 사이에 배치된 1층 이상의 유기물층을 포함하는 유기전계발광소자로서,
상기 유기물층 중 1 층 이상은 청구항 1 내지 7 중 어느 한 항에 따른 [화학식 1] 내지 [화학식 2]의 유기발광 화합물을 포함하는 것인 유기전계발광소자.
1. An organic electroluminescent device comprising a first electrode, a second electrode, and at least one organic material layer disposed between the first electrode and the second electrode,
Wherein at least one of the organic material layers contains an organic light emitting compound represented by any of formulas (1) to (2) according to any one of claims 1 to 7.
제8항에 있어서,
상기 유기물층은 정공 주입층, 정공 수송층, 및 정공 주입 및 정공 수송을 동시에 하는 층 중 1층 이상을 포함하고, 상기 층들 중 1층 이상이 상기 [화학식 1] 또는 [화학식 2]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
9. The method of claim 8,
Wherein the organic material layer includes at least one of a hole injecting layer, a hole transporting layer, and a layer simultaneously injecting holes and transporting holes, wherein at least one of the layers is an organic light emitting layer represented by the following Formula 1 or Formula 2 Wherein the organic compound is a compound represented by the following formula (1).
제8항에 있어서,
상기 유기물층은 발광층을 포함하고, 상기 발광층이 상기 [화학식 1] 또는 [화학식 2]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
9. The method of claim 8,
Wherein the organic layer includes a light emitting layer, and the light emitting layer comprises an organic light emitting compound represented by Formula 1 or Formula 2.
제10항에 있어서,
상기 [화학식 1] 또는 [화학식 2]로 표시되는 유기발광 화합물은 상기 발광층 내의 호스트 화합물 또는 도판트 화합물인 것을 특징으로 하는 유기전계발광소자.
11. The method of claim 10,
Wherein the organic luminescent compound represented by Formula 1 or Formula 2 is a host compound or a dopant compound in the luminescent layer.
제8항에 있어서,
상기 유기물층은 전자 수송층, 전자 주입층, 및 전자 수송 및 전자 주입을 동시에 하는 층 중 1층 이상을 포함하고, 상기 층들 중 1층 이상이 상기 [화학식 1] 또는 [화학식 2]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
9. The method of claim 8,
Wherein the organic material layer includes at least one of an electron transporting layer, an electron injecting layer, and a layer simultaneously carrying out electron transport and electron injection, and at least one of the layers is an organic light emitting layer represented by the above Chemical Formula 1 or 2 Wherein the organic compound is a compound represented by the following formula (1).
제8항에 있어서,
상기 유기물층에 적색, 녹색 또는 청색 발광을 하는 유기 발광층을 하나 이상을 더 포함하여 백색 발광을 하는 것을 특징으로 하는 유기전계발광소자.
9. The method of claim 8,
Wherein at least one of the organic light emitting layers emitting red, green or blue light is further included in the organic material layer to emit white light.
KR1020140039903A 2014-04-03 2014-04-03 An electroluminescent compound and an electroluminescent device comprising the same KR101638073B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140039903A KR101638073B1 (en) 2014-04-03 2014-04-03 An electroluminescent compound and an electroluminescent device comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140039903A KR101638073B1 (en) 2014-04-03 2014-04-03 An electroluminescent compound and an electroluminescent device comprising the same

Publications (2)

Publication Number Publication Date
KR20150115225A true KR20150115225A (en) 2015-10-14
KR101638073B1 KR101638073B1 (en) 2016-07-08

Family

ID=54357419

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140039903A KR101638073B1 (en) 2014-04-03 2014-04-03 An electroluminescent compound and an electroluminescent device comprising the same

Country Status (1)

Country Link
KR (1) KR101638073B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190082590A (en) * 2018-01-02 2019-07-10 (주)피엔에이치테크 An electroluminescent compound and an electroluminescent device comprising the same
WO2021220952A1 (en) * 2020-04-28 2021-11-04 東洋紡株式会社 Nitrogen-containing heterocyclic compound and use thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114685287A (en) * 2022-04-19 2022-07-01 上海钥熠电子科技有限公司 Triarylamine compound, organic electroluminescent device containing the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE571971C (en) * 1930-12-28 1933-03-09 I G Farbenindustrie Akt Ges Process for the preparation of aceanthrene and its derivatives
WO2008140132A1 (en) * 2007-05-16 2008-11-20 Canon Kabushiki Kaisha Benzo[a]fluoranthene compound and organic light emitting device using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE571971C (en) * 1930-12-28 1933-03-09 I G Farbenindustrie Akt Ges Process for the preparation of aceanthrene and its derivatives
WO2008140132A1 (en) * 2007-05-16 2008-11-20 Canon Kabushiki Kaisha Benzo[a]fluoranthene compound and organic light emitting device using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. Org. Chem. 1984, 49, 2069-2071 *
J. Org. Chem. 1985, 50, 277-279 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190082590A (en) * 2018-01-02 2019-07-10 (주)피엔에이치테크 An electroluminescent compound and an electroluminescent device comprising the same
WO2021220952A1 (en) * 2020-04-28 2021-11-04 東洋紡株式会社 Nitrogen-containing heterocyclic compound and use thereof

Also Published As

Publication number Publication date
KR101638073B1 (en) 2016-07-08

Similar Documents

Publication Publication Date Title
KR101825405B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101852926B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101530266B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20170082459A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627691B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101842013B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101626524B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101790550B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160127429A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20150110101A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160054870A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101837048B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101597865B1 (en) New compounds and organic electronic device using the same
KR101666826B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101913628B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101713530B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627695B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR102316570B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160077735A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627693B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101638073B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101816810B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20170003470A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101891714B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101837049B1 (en) An electroluminescent compound and an electroluminescent device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant